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Abstract
The Reelin signaling cascade is an important pathway in the development of the brain of
vertebrates, guaranteeing proper lamination of cerebellum, cerebral cortex, and hippocam-
pus. The matrix protein Reelin controls positioning of migrating neuroblasts by binding to
two receptors on their cell surface, ApoER2 and VLDL receptor. Both receptors transmit
the signal into the cell which results in phosphorylation of the intracellular adapter protein
Dab1. To a certain extent, both receptors can compensate for each other, and only the
loss of both results in a phenotype similar to that of reeler mice which lack funtional Reelin.
Nevertheless, both receptors also have specific distinct functions, as corroborated by analyses
of the subtle phenotypes displayed in mice lacking either ApoER2 or VLDL receptor. This
study focusses on those functional differences between the two Reelin receptors. ApoER2
and VLDLR were studied and compared in terms of sorting within the plasma membrane,
mechanism of endocytosis, Reelin internalization rate, intracellular traffic, degradation, and
proteolytic processing. Moreover, regulation of ApoER2 and VLDL receptor levels by a
liver X receptor mediated degradation pathway recently described for related receptors was
investigated. Using a panel of chimeric receptors, composed of extracellular, transmembrane
and intracellular domains of ApoER2 and VLDL receptor in diverse combinations, it was
furthermore analysed if differential behaviour is structurally determined or based on specific
sorting of the receptors to lipid raft or non-raft domains of the plasma membrane. The
different fates of ApoER2 and VLDL receptor after Reelin binding which are demonstrated
here could affect further signaling and might therefore constitute a mechanism for finetun-
ing of the Reelin pathway. VLDL receptor, residing in the non-raft domain, internalizes and
destines Reelin for degradation via the clathrin-coated pit/clathrin-coated vesicle/endosome
pathway without being degraded to a significant extent. Binding of Reelin to ApoER2, resi-
dent of rafts, leads to the production of particular receptor fragments with specific functions
of their own and to degradation of ApoER2 via lysosomes. These features contribute to a
novel model that emphasizes negative feedback loops specifically mediated by ApoER2 and
VLDL receptor, respectively.
3

Zusammenfassung
Der Reelin Signalweg gewa¨hrleistet in der Hirnentwicklung von Vertebraten die korrekte
Schichtung des Cerebellums, des cerebralen Cortex und des Hippocampus. Das Matrix-
Protein Reelin steuert dabei wandernde Neuroblasten, indem es an zwei ihrer Membranrezep-
toren, ApoER2 und VLDL Rezeptor, bindet. Beide Rezeptoren u¨bermitteln dieses Signal in
die Zelle, wo es zu Phosphorilierung des Adapterproteins Dab1 fu¨hrt. Bis zu einem gewissen
Grad ko¨nnen ApoER2 und VLDL Rezeptor den Verlust des jeweils anderen kompensieren.
Daher fu¨hrt nur der Verlust beider Rezeptoren zum Reeler Pha¨notyp, der auch bei Ma¨usen
mit fehlerhaftem Reelin Protein auftritt. Dennoch haben beide Rezeptoren zusa¨tzliche
individuelle Funktionen, wie die weniger ausgepra¨gten, aber spezifischen Pha¨notypen von
ApoER2- oder VLDL Rezeptor-defizienten Ma¨usen vermuten lassen. Diese Arbeit konzen-
triert sich auf ebendiese funktionellen Unterschiede der Reelin Rezeptoren. ApoER2 und
VLDL Rezeptor wurden in Hinblick auf Lokalisierung in der Plasmamembran, Endozytose-
mechanismus, zellula¨re Reelin-Aufnahme, intrazellula¨re Sortierung, Prozessierung und Ab-
bau verglichen. Weiters wurde die Regulation der Rezeptormenge durch einen erst ku¨rzlich
beschriebenen Liver-X-Rezeptor-abha¨ngigen Abbauweg untersucht. Mit Hilfe von chima¨ren
Rezeptoren aus den Extrazellula¨r-, Transmembran- und Intrazellula¨rdoma¨nen von ApoER2
und VLDL Rezeptor wurden des Weiteren strukturelle Eigenschaften sowie Membranlokali-
sation innerhalb oder ausserhalb von Lipid Rafts als mo¨gliche Ursachen fu¨r die rezeptorspez-
ifischen Besonderheiten gegenu¨bergestellt. Die hier demonstrierten, unterschiedlichen Wege
von ApoER2 und VLDL Rezeptor nach der Bindung von Reelin ko¨nnten eine Feinabstim-
mung des Reelin Signalwegs darstellen. VLDL Rezeptor, welcher ausserhalb der Lipid Raft-
Fraktion der Plasmamembran zu finden ist, internalisiert Reelin u¨ber den Clathrin-coated
pit/Clathrin-coated vesicle/Endosom-Weg und fu¨hrt es so dem Abbau zu, ohne selbst abge-
baut zu werden. Bindung von Reelin an den Lipid Raft-assoziierten ApoER2 fu¨hrt zur Pro-
duktion von spezifischen Rezeptorfragmenten und zum lysosomalen Abbau des Rezeptors.
Anhand dieser Ergebnisse wurde ein neues Modell des Reelin Signalwegs entwickelt, welches
spezifische Ru¨ckkopplungs-Effekte durch ApoER2 und VLDL Rezeptor miteinbezieht.
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1 Introduction
1.1 The LDL receptor family in endocytosis and signaling
The low density lipoprotein (LDL) receptor family comprises several closely related trans-
membrane proteins which are involved in both molecular transport and signal transduction
in a wide range of physiological functions in different tissues (reviewed in May et al., 2007;
Nykjaer and Willnow , 2002). The major domain pattern common to all members of this
protein family can be found in LDL receptor relatives throughout a variety of eukaryotic
multicellular species from C.elegans (Yochem and Greenwald , 1993) to rat (Saito et al.,
1994) and human (Herz et al., 1988), which highlights the evolutionary conservation and
importance of this ancient gene family.
Originally, members of this gene family were solely known for their endocytic function. First
and foremost, the eponymous family member, LDL receptor (LDLR), plays an important
role in cholesterol homeostasis since it binds lipoprotein particles from the bloodstream and
mediates their uptake into and lysosomal degradation within cells of the liver and peripheral
organs. It was this receptor, study of which first led to the understanding of the mechanism of
receptor-mediated endocytosis (Anderson, 1977; Brown and Goldstein, 1986; Goldstein et al.,
1985). In 1985, Michael S. Brown and Joseph L. Goldstein were awarded the Nobel prize
in Medicine for revealing the implications of the LDL receptor pathway on the regulation
of cholesterol metabolism. Meanwhile, however, the functions of the LDL receptor family
were extended to participation in signaling cascades by transmitting extracellular signals to
intracellular adapter proteins. They play important additional roles in health and disease
and are for example involved in regulation of neuronal migration in embryonic and adult
brain (Andrade et al., 2007; Blake et al., 2008; Herz et al., 2000), synaptic plasticity and
memory (D’Arcangelo, 2005; Qiu et al., 2002), development of Alzheimer’s disease (Ulery
et al., 2000) and atherosclerosis (Boucher et al., 2003), tumor progression (Liu et al., 2000),
and digit differentiation (Johnson et al., 2005).
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1.1.1 Structural and functional features of LDL receptor relatives
To date, seven core members of the mammalian LDL receptor family have been reported.
In addition to LDLR itself, these are apolipoprotein E receptor 2 (ApoER2, also referred to
as LRP8), very low density lipoprotein receptor (VLDLR), the LDLR-related protein (LRP,
also referred to as LRP1), LRP1b, MEGF7 (also referred to as LRP4) and Megalin (also
referred to as gp330 or LRP2). More distantly related members of the family which do not
completely fit into the tight structural definition of the family core, are LRP5, LRP6, and
SorLA (also referred to as LR11). The core members of the receptor family share a common
modular structure which is composed of five distinct domains: (i) an extracellular ligand
binding domain, (ii) an epidermal growth factor (EGF) precursor homology domain, (iii)
an O-linked sugar domain, (iv) a transmembrane domain, and (v) a cytoplasmic domain
(reviewed in Gent and Braakman, 2004) (Fig. 1.1).
The extracellular ligand binding domain is composed of multiple LDL receptor type A
(LA) repeats, each of which consists of approximately 40 amino acids including six cys-
teine residues forming disulfide bonds. In addition, each LA repeat comprises a conserved
sequence rich in acidic amino acids which can bind a calcium ion (Fass et al., 1997). This
is essential for functionality of the extracellular domain since the incorporation of calcium
is necessary for correct disulfide bond formation and maintenance of the structural integrity
of the domain (Atkins et al., 1998; Blacklow and Kim, 1996) and is a prerequisite for ligand
binding (Daniel et al., 1983; Schneider et al., 1979). Residues involved in binding and coor-
dination of the ion become surface-exposed, thereby creating a characteristic site of negative
surface potential which can establish electrostatic interactions with complementary charged
surfaces on the respective ligands (Fisher et al., 2006).
Prevention of premature ligand association during receptor synthesis and trafficking to the
plasma membrane is an essential task, since cells which pack and export lipoproteins, the
major binding partners for the gene family, also express LDLR and its relatives (Twisk
et al., 2000). It was shown that the receptor-associated protein (RAP), an endoplasmic
reticulum (ER) resident protein of 39 kDa, is at neutral pH able to bind the LA repeats of
all core members of the LDLR family examined to date (Battey et al., 1994; Iadonato et al.,
1993; Kounnas et al., 1992; Medh et al., 1995; Stockinger et al., 1998). In the cell, RAP
binding blocks any unspecific and undesirable interactions with other ligands and thereby
facilitating receptor trafficking within the early secretory pathway and delivery to the cell
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Figure 1.1 The modular structure of LDL receptor family members. These receptors contain five
distinct modules: LA-repeats, EGF precursor homology domains, O-linked sugar domain, transmembrane
domain, and a cytoplasmic tail harboring one or more NPxY motifs. Differentially spliced structures are
depicted hatched.
surface (Bu et al., 1995; Willnow et al., 1996b). When the RAP-receptor complex reaches
the Golgi apparatus, the low pH condition there induces dissociation of the binding partners
(Bu et al., 1995). In addition to its function as an escort protein, RAP may also assist in
the folding of the receptors (Bu and Rennke, 1996)
In all LDLR family core members, the ligand binding domain is followed by one or more EGF
precursor homology domains, also referred to as LDL receptor type B repeats. These modules
include cysteine-rich growth factor repeats of about 40 amino acids (EGF-like repeats) which
are flanking the major components of these domains, six YWTD motifs (containing the
consensus tetrapeptide Tyr-Trp-Thr-Asp). These motifs enable the buildup of a six-bladed
β-propeller structure (Jeon et al., 2001; Springer , 1998) (Fig. 1.2) which is implicated in the
11
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Figure 1.2 Ribbon representation of the six-bladed β-
propeller structure and adjacent C-terminal EGF-like
module (E3) of the LDL receptor.. View down the central
axis of the propeller. Each blade of the propeller consists of four
antiparallel β-strands. Each second innermost strand (labeled
2) contains a YWTD consensus sequence. (Taken from Jeon
et al., 2001).
pH-dependent dissociation of receptor and ligand in endosomes (Davis et al., 1987; Rudenko
et al., 2002).
LDL binding to LDL receptor essentially occurs at ligand binding repeats 4 and 5. By
structural analysis it was shown that at endosomal pH, these two repeats intramolecularly
fold back toward the β-propeller (Rudenko et al., 2002). This results in a closed conformation
not able to sustain LDL binding (Fig. 1.3). Therefore, the current model implies that this
competition for LA repeats is responsible for the release of bound ligands from LDL receptor
family members at low pH in the endosomal compartment.
Figure 1.3 Model for the pH-dependent release of LDL from its receptor. Ligand binding modules
3-7 participate in binding of LDL at neutral pH, whereas modules 4 and 5 are engaged in intramolecular
contacts with the YWTD β-propeller domain at endosomal pH, leading to release of the lipoprotein.
Adjacent to the EGF precursor homology domain, the so-called O-linked sugar domain
(OLSD) can be found in some of the receptor family members, i.e. LDLR, and splice
variants of VLDLR and ApoER2. This short region is rich in serine and threonine residues
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which can undergo O-linked glycosylation. As it was shown, receptors glycosylated in this
way are less prone to proteolytic processing (Magrane´ et al., 1999; May et al., 2003) which
could imply differential biological functions of distinct receptor variants.
Following a single transmembrane domain of about 20 amino acids, all family members
contain a short cytoplasmic domain harboring one or more NPXY motifs (Asp-Pro-Xxx-
Tyr, where Xxx denotes any amino acid) (Chen et al., 1990). As they constitute the binding
sites for intracellular adapter proteins (Chen et al., 1990), these motifs are not only essential
for receptor-mediated signal transduction but also for internalization of ligands.
For clathrin-mediated endocytosis of membrane proteins, recruitment to clathrin-coated pits
in the plasma membrane by binding of adapter proteins is essential. These specialized
membrane regions are defined by the concentrated presence of the coat protein clathrin
which occurs in the form of triskelia, three-legged complexes built up from heavy and light
chains (Brodsky et al., 2001; Kirchhausen, 2000). Together with Adapter protein complex 2
(AP2), these structures form polygonal cages at the plasma membrane (coated pits) which
are able to invaginate and pinch off the membrane to form clathrin-coated vesicles (CCVs).
This is facilitated by the GTPase dynamin which is believed to form a collar around the
neck of the invaginated pit (Fig. 1.4). CCVs are released into the cytoplasm and deliver
their cargo to the endosomal system after shedding the clathrin coat.
Figure 1.4 Clathrin-mediated endocytosis. Cargo-loaded receptors are recruited to coated pits where
they interact with clathrin via binding of AP2 and adapter proteins, i.e. ARH in the case of LDLR. Clathrin
triskelions crosslink to build a polygonal structure which facilitates invagination of the coated pit. At the
neck of the invaginated pit, dynamin assembles to form a collar and drive membrane fission and release of
the coated vesicle into the cytoplasm.
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In the case of LDLR family members, adapter proteins enabling clathrin-mediated endocy-
tosis are disabled 2 (Dab2) and autosomal recessive hypercholesterolemia (ARH), which in
turn assemble with AP2 (Mishra et al., 2002; Morris and Cooper , 2001) to recruit the recep-
tors to coated pits. Additionally, the NPXY motif also binds adapter molecules responsible
for relaying a signal into the cell, as it is the case for disabled 1 (Dab1) transmitting the
Reelin signal (see section 1.2).
1.1.2 The LDL receptor in lipid metabolism
LDL receptor was the first member of the gene family to be discovered and is the best studied
one, so far. This receptor is implicated in the maintainance of cholesterol homeostasis by
mediating cellular uptake and catabolism of plasma cholesterol.
In order to enable transportation within the circulation, cholesterol and other lipids are pack-
aged into lipoprotein particles assembled from lipids and proteins. These particles consist of
a lipid core composed of esterified cholesterol and triglycerides, surrounded by a monolayer
of phospholipids and unesterified cholesterol (Fig. 1.5). Depending on their triglyceride pro-
portion and their buoyant density, lipoprotein particles are grouped into five subcategories:
chylomicrons, very low density lipoproteins (VLDL), intermediate density lipoproteins (IDL),
low density lipoproteins (LDL), and high density lipoproteins (HDL), in the order of increas-
ing density and decreasing triglyceride portion. Associated with the surface of lipoprotein
particles are apolipoproteins which are essential for recognition of lipoprotein particles by
enzymes, receptors, and for interaction with one another.
Figure 1.5 Structure of lipoproteins. Lipoproteinparticles are composed of a lipid core contain-
ing cholesteryl esters and triglycerides, and a surface coat of phospholipids, unesterified cholesterol and
apolipoproteins.
14
1.1 The LDL receptor family in endocytosis and signaling
Lipid metabolism in mammals employs two interacting pathways which control the fate
of lipids delivered by diet (exogenous pathway) and newly synthesized lipids (endogenous
pathway). In the exogenous pathway, dietary lipids are taken up by epithelial cells of the in-
testinal mucosa, packaged into chylomicrons and released into the circulation via the lymph.
In the blood stream, part of the chylomicrons’ triglycerides are extracted and hydrolyzed
by lipoprotein lipase (LPL), thereby releasing glycerol and fatty acids which can be taken
up by cells of peripheral tissues, especially muscle, for energy generation and stored by adi-
pose tissue. The triglyceride-deprived particles, now called chylomicron remnants, bind to
receptors (LDLR and LRP) on hepatocytes and are internalized via receptor-mediated en-
docytosis and degraded within lysosomes to provide the cells with glycerol, fatty acids, and
cholesterol.
Endogenous lipids, i.e. triglycerids and cholesterol originating from the liver, are released to
the circulation in the form of VLDL particles. In a manner similar to the fate of chylomicrons,
VLDL donates triglycerides to peripheral tissues. The particle itself is thereby converted
to VLDL remnants, called IDL, and LDL by further triglyceride extraction. LDL particles,
whose lipid portion is mainly composed of cholesterol and phospholipids now, are absorbed
by peripheral tissues or circulate back to the liver. In both cases, apoliporotein B-100 (apoB-
100) on the surface of LDL particles binds to LDL receptor on target cells and the lipoprotein
is internalized via receptor-mediated endocytosis. Excess cholesterol is collected from the
tissues by HDL and delivered back to the liver.
Internalization of LDL particles after binding to LDLR occurs via clathrin-mediated en-
docytosis (originally referred to as receptor-mediated endocytosis, Goldstein et al., 1985).
After delivery of receptor and ligand to the endosomal compartment, the slightly acidic pH
environment causes the receptor to change its conformation and to release its ligand (as
described in section 12). The vesicles where this process takes place are therefore known as
compartment of uncoupling of receptor and ligand (CURL). While LDLR recycles back to
the plasma membrane, LDL is delivered to the lysosome for degradation. Released choles-
terol is important for use in the buildup of cell membranes and synthesis of bile acids and
steroid hormones. The LDL receptor pathway is summarized in Fig. 1.6.
As a response to the release of cholesterol from lipoprotein particles, the cell initiates sev-
eral feedback pathways to prevent overacculmulation of cholesterol (Brown and Goldstein,
1986). To shut down further lipoprotein uptake, LDL receptor expression is downregulated.
Furthermore, 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA) synthase and HMG-CoA
15
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Figure 1.6 The LDL receptor pathway. Mature LDL receptor is released from the Golgi body and
transported to the plasma membrane by the secretory pathway. Upon binding of its ligand LDL, the receptor
is recruited to clathrin coated pits and internalized via clathrin mediated endocytosis. In the endosome, pH
change leads to release of LDL which is subsequently degraded in the lysosome to release cholesterol and
amino acids. LDL receptor is recycled back to the plasma membrane where it is available for internalization
of more LDL from the circulation. Ccv, clathrin coated vesicle.
reductase, two important enzymes in the biosynthesis of cholesterol, are suppressed, and acyl-
CoA-cholesterol:acyltransferase (ACAT) which facilitates the storage of excess cholesterol as
cholesterol esters is activated.
Regulation of the genes for LDL receptor and enzymes neccessary for cholesterol synthesis
is mediated by sterol response element binding proteins (SREBPs) which normally bind to
sterol response elemens in the DNA to activate gene transcription. In the situation of high
intracellular cholesterol levels, SREBPs cannot undergo the proteolytical cleavage which is
neccessary for their activation, resulting in downregulation of gene expression and reduced
cholesterol uptake and synthesis (reviewed in Weber et al., 2004).
By delivery of cholesterol to the liver and peripheral tissues, LDL receptor not only supplies
cells with cholesterol but also ensures efficient clearance of lipoproteins from the circula-
tion. Disruption of this major task by genetically altered receptor molecules causes a major
problem for systemic lipid metabolism. The resulting disorder is called familial hypercholes-
terolemia (FH) in humans and is characterized by accumulation of LDL in the circulation
16
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due to defective uptake into tissues. Symptoms caused by elevated plasma LDL levels are
atherosclerosis and heart attacks.
FH can be caused by mutations affecting the synthesis of LDL receptor in the endoplasmic
reticulum (ER), transport to and modification in the Golgi body, binding of LDL, endocyto-
sis of the receptor-ligand complex, and recycling of the receptor after ligand internalization.
Also mutations in the genes for ARH or ApoB, or gain-of-function mutations of the pro-
protein convertase subtilisin/kexin type 9 (PCSK9) can cause FH (reviewed in Soutar and
Naoumova, 2007). PCSK9 induces lysosomal degradation of LDL receptor by binding to
LDLR’s first EGF precursor homology domain which results in interference with its recy-
cling by a yet unknown mechanism (Zhang et al., 2007).
Recently, another regulatory mechanism for LDL receptor availability involving liver X re-
ceptors (LXRs) and Mylip/Idol has been reported (Zelcer et al., 2009).
LXRs (LXRα and LXRβ) are nuclear receptors which act as transcription factors upon bind-
ing of an activating ligand. LXR forms a heterodimer with retinoid X receptor (RXR) (Apfel
et al., 1994). In a resting state, the receptor complex binds to LXR-responsive elements
(LXREs) on the promoter of target genes (Wiebel and Gustafsson, 1997) and suppresses
gene transcription by recruiting corepressors such as silencing mediator of retinoic acid and
thyroid hormone receptor (SMRT) and nuclear receptor corepressor (NCOR) to the DNA
(Chen and Evans, 1995; Ho¨rlein et al., 1995). Upon binding of a ligand to either LXR or
RXR (Wiebel and Gustafsson, 1997), conformational changes lead to release of these core-
pressors and interaction with specific coactivators, resulting in activation of gene expression
(Glass and Rosenfeld , 2000).
LXRs are involved in the regulation of several physiological functions in lipid, bile acid and
glucose metabolism, immune and inflammatory responses, and energy balance (reviewed in
Baranowski , 2008; Gabbi et al., 2009; Zelcer and Tontonoz , 2006).
One prominent role of LXRs is systemic cholesterol homeostasis. More specifically, this
includes hepatic excretion of cholesterol into bile (Peet et al., 1998; Yu et al., 2003), intestinal
cholesterol absorption (Repa et al., 2002, 2000), de novo cholesterol synthesis (Peet et al.,
1998; Schultz et al., 2000), reverse cholesterol transport from peripheral cells to the liver via
HDL particles (Lewis and Rader , 2005; Naik et al., 2006), and, as recently reported, LDLR
degradation (Zelcer et al., 2009).
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In the regulation of cellular LDL receptor levels, LXR is activated by binding of metabolized
cholesterol derivates (oxysterols) (Lehmann et al., 1997) and induces expression of genes
which prevent excess cholesterol accumulation, among them the inducible degrader of the
LDLR (Idol) (Zelcer et al., 2009).
Idol, also known as Mylip, is an E3 ubiquitin ligase which upon LXR-driven expression,
induces ubiquitination of LDL receptor and its subsequent degradation (Zelcer et al., 2009).
Although generally, ubiquitination leads to proteasomal degradation, in this case LDL re-
ceptor is broken down in the lysosome in response to Idol action (Zelcer et al., 2009).
Since excess cholesterol in the cell activates both PCSK9 and the LXR/Idol pathway, leading
to the same result - lysosomal degradation of LDLR - the two mechanisms may cooperate.
One possibility would be PCSK9-dependent ubiquitination of LDLR by Idol (Sawamura,
2009). This model however, is only hypothetical and to date, lacks any experimental evi-
dence.
1.1.3 VLDL receptor
VLDL receptor is most closely related to LDLR. The two proteins share an almost identical
domain structure except for one additional LA repeat in VLDLR. This difference however,
determines slightly different binding characteristics of VLDLR. Whereas LDLR preferably
interacts with LDL, VLDL receptor recognizes triglyceride-rich apoE-containing lipopro-
teins, i.e. VLDL, IDL, and chylomicrons but not LDL. Furthermore, VLDL receptor also
binds ligands which are not involved in lipid metabolism which is currently ruled out in
case of LDLR. These ligands include urokinase plasminogen activator (uPA)/plasminogen
activator inhibitor-1 complex (Battey , 1995), lipoprotein lipase (Battey , 1995), tissue factor
pathway inhibitor (TFPI) (Hembrough et al., 2001), Reelin (Hiesberger et al., 1999) and
Thrombospondin (Mikhailenko et al., 1997).
Mammalian VLDLR mRNA was found to be differentially spliced, generating receptor vari-
ants containing or lacking the O-linked sugar domain with the shorter isoforms seeming to
be less stable at the cell surface (Magrane´ et al., 1999). In addition, a brain-specific isoform
with seven LA repeats was identified which lacks exon 4 (corresponding to LA repeat 3)
(Christie et al., 1996; Takahashi et al., 2004). Only isoforms with eight LA repeats occur in
chicken. Here, VLDLR containing the OLSD can be found in somatic cells, predominantly
18
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heart and muscle, while receptors lacking the domain are expressed by oocytes (Bujo et al.,
1995a).
In mammals, VLDLR expression is highest in skeletal muscle, heart, and adipose tissue, less
in brain, and very low in liver (Wyne et al., 1996). Due to this expression pattern and the
receptor’s strong interaction with apoE, its physiological role was believed to be the delivery
of triglyceride-rich particles such as VLDL to peripheral tissues (Wyne et al., 1996) or the
immobilization of these particles on the surface of endothelial cells in order to facilitate LPL
action facilitating delivery of free fatty acids to the adjacent tissue. This was suggested by the
findings of LPL-induced enhancement of VLDLR-VLDL-interaction (Takahashi et al., 1995),
enhancement of LPL action by VLDLR (Goudriaan et al., 2004), and involvement of VLDLR
in LPL transcytosis across endothelial cells (Obunike et al., 2001). Surprisingly, it was shown
that VLDLR deficiency did not result in altered lipoprotein profiles in mice, nor in significant
changes in body weight or adipose tissue mass (Frykman et al., 1995). Nevertheless, a role for
VLDLR in fatty aicd uptake by adipose tissue could be concluded from the partial resitance
of knockout mice to diet-induced obesity (Goudriaan et al., 2001). A significant increase in
serum triglyceride levels however, could only be detected in LDLR/VLDLR double knockout
mice on a high-fat diet (Tacken et al., 2000), pointing to a partial compensation by LDLR
in VLDLR knockout mice.
As suggested by the wide variety of ligands binding to VLDLR, the receptor is also implicated
in many different functions beyond lipoprotein metabolism, and was found to play impor-
tant roles in signal transduction, angiogensis, and tumor growth. Together with Throm-
bospondins, for example, VLDLR mediates a nonapoptotic pathway to inhibit cell division
in microvascular endothelial cells, by inhibiting thymidine uptake (Oganesian et al., 2008).
In mammalian brain development and in the postnatal brain, the receptor acts as a signal
transducer in the Reelin pathway together with ApoER2 (see section 1.2). In men, VLDLR
deficiency was recently linked to dysequilibrium syndrome with ataxia and mental retarda-
tion which results from profound cerebellar hypoplasia (Boycott et al., 2009; Moheb et al.,
2008; Ozcelik et al., 2008; Tu¨rkmen et al., 2008).
In avian species, VLDL receptor is expressed in the same tissues as in mammals, but addi-
tionally plays an important role in oocyte development by acting as an endocytic receptor
for yolk precursors.
When an oocyte is chosen for final maturation and ovulation in the chicken ovulatory cycle,
19
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a phase of rapid growth, uptake of plasma components from the circulation, and their depo-
sition as yolk are initiated (Perry et al., 1978). One major part of the yolk are lipoproteins,
mainly VLDL and vitellogenin (VTG) which are synthesized by the liver, secreted to the cir-
culation, and taken up by growing oocytes via VLDL receptor-mediated endocytosis. Seven
days after growth phase initiation, when the oocyte has reached its full size, it is released
from the follicle, i.e. it ovulates, which finally causes egg production.
In the absence of VLDLR, the oocyte is not able to enter the rapid growth phase, and egg-
laying is disturbed. Additionally, the lipoproteins not transported to the growing oocyte re-
main in the circulation of the hen which in turn shows signs of hyperlipidemia and atheroscle-
rosis (Bujo et al., 1995b).
Yolk precursors extracted from the circulation have to pass the theca cell layer (composed of
theca externa and interna), the basement membrane, an epitheloid monolayer of granulosa
cells, and the zona pellucida before reaching VLDLR which mediates their uptake into the
growing oocyte in order to form yolk (Fig. 1.7).
Passing of the theca layers is possibly facilitated by perlecan, originally known as a basement
membrane protein in other species which, in chicken, is found in the extracellular matrix
(ECM) of theca externa cells (Hummel et al., 2004). It is able to bind VLDL and is probably
used by the follicle to import and store VLDL within the ECM for subsequent uptake into
the oocyte (Barber et al., 1991; Perry and Gilbert , 1979; Shen et al., 1993) (reviewed in
Schneider , 2009). For this purpose, VLDL might then be transported to and through the
basement membrane via interaction with the protein ggBM1 (Hummel et al., 2007). Passage
through the monolayered granulosa cells is accomplished by diffusion through gaps between
the cells.
1.1.4 ApoE receptor type 2
ApoER2 is almost exclusively expressed in brain in chicken, and brain, testis, and placenta
in mammals (Brandes et al., 1997). Homozygous knockout mice show no obvious severe phe-
notype but male animals are sterile, suggesting that ApoER2 might be involved in sperm
production (Trommsdorff et al., 1999). As the very low endocytosis rate of ApoER2 com-
pared to other members of the LDLR family suggests, the primary function of this receptor
seems to lie in signaling rather than receptor-mediated endocytosis (Li et al., 2001). Indeed,
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Figure 1.7 Uptake of yolk precursors to the chicken follicle in the pre-ovulatory growth phase.
Yolk precursors, transported from the liver to the follicle via the circulation traverse theca interna and externa,
basement membrane, granulosa cell layer, and zona pellucida before passing the oocyte membrane by receptor
mediated endocytosis.
it is one of the two receptors mediating the Reelin signaling pathway in mammalian brain
development (see section 1.2).
ApoER2 can be found in a multitude of splice variants, harbouring different numbers of LA
repeats and containing or lacking the O-linked sugar domain, a furin cleavage site and a
short proline-rich insert in the cytoplasmic tail.
Depending on the species and organ expressing it, ApoER2 can contain three to eight LA
repeats. Murine ApoER2 has beed found in several isoforms, all lacking exon 5 which codes
for LA-repeats 4-6 and is constitutively spliced in this species. Therefore the variant with
the largest ligand binding domain contains the five remaining repeats 1-3, 7, and 8. In
other ApoER2 molecules, LA repeat 8 is either missing or replaced by a 13 amino acid long
furin consensus cleavage site (Brandes et al., 2001). By cleavage by the serine endoprotease
furin, a soluble receptor fragment containing the entire ligand binding domain consisting
of four LA-repeats is produced (Fig. 1.8). The secreted fragment is able to block Reelin
signaling in primary neurons (Koch et al., 2002), which suggests a role for this splice variant
in negative feedback-regulation of the signaling pathway in vivo. Also in human ApoER2,
an alternatively spliced furin site was reported (Brandes et al., 1997). Splicing of the ligand
binding domain in men produces variants with LA repeats 1-3, 1-3 and 7, but also the whole
seven repeats (Kim et al., 1997). In chicken, isoforms with seven or eight LA repeats have
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been found. Both do not contain a furin cleavage site (Brandes et al., 1997).
Just like VLDL receptor, ApoER2 has been found to differentially express an O-linked sugar
domain in mice which as expected is more susceptable to proteolytic processing, too (May
et al., 2003). In response to ligand binding, ApoER2 variants containing this domain can
be cleaved by α-secretase at a site just outside the plasma membrane to generate a soluble
extracellular fragment (N-terminal fragment, NTF) and a membrane-bound C-terminal frag-
ment (CTF) which can be further processed by γ-secretase to release a soluble intracellular
fragment (ICD) (Hoe and Rebeck , 2005; May et al., 2003) (Fig. 1.8). Further trafficking or
functions of NTF and ICD are not quite clear yet. However, the NTF might act as negative
regulator for the Reelin pathway, as it was shown for the furin-generated fragment. The
ICD might either be efficiently and rapidly degraded or shuttled to the nucleus by Dab1.
Regulation of gene expression by proteolytic fragments has been shown in the case of notch
(Okochi et al., 2002), APP (Gao and Pimplikar , 2001), and others. Either way, the ICD
seems to be removed from the cytoplasm very quickly, since it is constantly hard to detect
there.
Figure 1.8 Secretase-mediated processing of ApoER2. ApoER2 variants containing the furin cleav-
age site can be processed to release the ligand binding domain to the extracellular space. Upon ligand binding,
ApoER2 is subjected to two consecutive cleavage events. By α-secretase processing, a soluble N-terminal and
membrane-bound C-terminal fragment (NTF and CTF, respectively) are produced. Further fragmentation
by γ-secretase releases the soluble intracellular domain (ICD) from the membrane into the cytoplasm.
Another feature is exclusively known for ApoER2: a 59 amino acid long proline-rich insert
in the receptor’s cytoplasmic tail, encoded by a single exon, occurs in some isoforms of
the murine and human (but no chicken) receptor (Brandes et al., 1997). Binding of JIP-1
(JNK interaction protein 1) and JIP-2 has been shown to occur at this region (Stockinger
et al., 2000). JIP and c-jun N-terminal kinase (JNK) are major proteins of the MAP kinase
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pathway (Yasuda et al., 1999). Another adaptor protein binding to the proline-rich insert
is the postsynaptic density protein PSD-95 which interacts with both ApoER2 and the
N-methyl-D-aspartate (NMDA) type gutamate receptor simultaneously in the presence of
Reelin. This interaction plays a role in synaptic plasticity and memory in the adult brain
by regulating synaptic calcium influx via the NMDA receptor (D’Arcangelo, 2005).
As it was show recently, ApoER2 is mainly found in lipids rafts (Mayer et al., 2006; Riddell
et al., 2001), small specialized cholesterol- and sphingolipid-rich microdomains of the plasma
membrane (see Fig. 1.9), moving freely within the cell surface (Brown and London, 2000).
This, is in contrast to LDLR and VLDLR which are strictly excluded from these membrane
domains. A special type or subdomain of lipid rafts are caveolae (Anderson, 1998; Kurzchalia
and Parton, 1999). The composition of caveolae is similar to that of lipid rafts, exept
for the additional presence of caveolin, a structural protein which occurs in homo- and
hetero-oligomers (Sargiacomo et al., 1995; Scherer et al., 1997) and is able to associate with
cholesterol (Murata et al., 1995) and glycophospholipids (Fra et al., 1995). These interactions
are believed to determine the observed flask-like ivaginated shape of caveolae (Sargiacomo
et al., 1995) (Fig. 1.9).
Figure 1.9 Schematic representation of lipid rafts and caveolae. Lipid rafts are freely moving
domains of the plasma membrane. They show a high concentration of cholesterol and sphingolipids. Caveolae
possess a similar lipid composition but are characterized by the additional presence of caveolin which associates
with the membrane to facilitate invagination.
Lipid rafts and especially caveolae are supposed to be implicated in signal transduction
rather than bulk endocytosis (Anderson, 1998; Razani et al., 2002), since caveolae show a
low internalization rate with a halftime of more than 20 minutes and carry little volume.
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Furthermore, many signaling receptors and membrane transporters are clustered in these
regions. Further evidence for a (negative) regulatory role of caveolin rather than importance
for the uptake machinery was supplied by the finding that experimentally reduced caveolin
levels tend to slightly accelerate raft-mediated uptake (Nabi and Le, 2003). The reason for
this could be stabilization of rafts by caveolin, as suggested by the observation that caveolae
are largely static.
However, endocytosis of proteins associated to lipid rafts, can occur by caveolae-dependent
or -independent mechanisms (Kirkham and Parton, 2005). In the case of ApoER2, inter-
nalization occurs via clathrin-mediated endocytosis, arranged by binding of Dab2, despite
the receptor’s localization to rafts (Cuitino et al., 2005). Nevertheless, ApoER2 endocytosis
could still be regulated by the presence of caveolin.
1.1.5 LDLR-related protein
LRP is a ubiquitously expressed large glycoprotein of about 600 kDa. After synthesis, it is
cleaved by furin in the trans-Golgi network which generates an extracellular and a trans-
membrane fragment remaining associated with one another (Herz et al., 1990). Furthermore,
LRP can be specifically processed like Notch and APP, generating a soluble extracellular and
intracellular fragment, likely to be involved in signaling mechanisms (May et al., 2002).
Homozygous LRP knockout mice die at early embryonic age which seemingly results from an
essential role of LRP during implantation of the embryo, when it mediates uptake and degra-
dation of urokinase-type plasminogen activator/plasminogen activator-inhibitor 1 complexes
(Herz , 1992).
Since this prevented study of LRP deficiency effects in vivo, Herz and collegues came up
with a mouse model permitting inducible, tissue specific disruption of the LRP gene using
Cre/loxP recombination (Rohlmann et al., 1998).
Using this model, it was shown that LRP mediates clearance of chylomicron remnants from
the plasma (Rohlmann et al., 1998) which is in accordance with the original identification of
the receptor as an endocytic receptor for apoE-rich lipoproteins in the liver (Beisiegel et al.,
1989). In addition, LRP mediates uptake and intracellular degradation of several more
ligands, i.e. activated α2-macroglobulin (α2-M
∗), factor VIII, and serpin-enzyme complexes
to the liver and is of great importance for diverse physiological functions in a broad range
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of tissues. Functions of LRP involve regulation of vascular permeability, regulation of cell
migration, control of cellular entry of bacterial toxins and viruses, and modulation of the
integrity of the blood-brain-barrier (reviewed in Lillis et al., 2008).
LRP expressed in the central nervous system binds α2-M
∗, which enables it to influence
synaptic plasticity via PSD-95 mediated interaction with NMDA receptors (Qiu et al., 2002).
Another important role of LRP in the brain lies in keeping the balance between production
and clearance of β-amyloid (Aβ), a proteolytic fragment of amyloid precursor protein (APP),
which is implicated in the pathology of Alzheimer’s disease in aggregates called amyloid
plaques. Cells deficient in LRP show increased cell surface levels of APP and reduced
Aβ amounts (Pietrzik et al., 2002; Ulery et al., 2000) which increases the risk of amyloid
plaques.
Although it could be determined that binding of LRP to APP occurs via the cytoplasmic
adapter protein Fe65 (Pietrzik et al., 2004), the pathway leading from LRP-APP interaction
to increased Aβ production is not entirely clear at present. According to the currently
proposed mechanism, association of APP with LRP leads to increased trafficking of APP
through the endosomal compartments where BACE and presenilin-1 (PS-1), the two cleaving
enzymes necessary for Aβ production are known to reside. This would lead to enhanced
proteolysis of APP (Fig. 1.10). As it was shown, in response to this, the intracellular
domain of APP, released after generation of Aβ, is able to suppress LRP transcription in a
complex with Fe65 and Tip60 (Liu et al., 2007).
In 2003, another role of LRP was discoverd in the maintainance of blood-brain-barrier (BBB)
function (Yepes et al., 2003). Here, tissue-type plasminogen activator (tPA)-regulated BBB
permeability seems to be regulated by LRP. This mechanism may also contribute to a role
of LRP in Alzheimer’s, since Aβ may be cleared from the brain through the BBB by LRP
(Shibata et al., 2000).
Moreover, LRP is essential for protection of the vasculature from atherosclerosis. Apart from
its role for lipoprotein uptake to the liver, it counteracts the development of atherosclerosis
also through other mechanisms triggered in vascular smooth muscle cells and macrophages.
While it was shown that LRP suppresses platelet-derived growth factor (PDGF) signaling
pathways in smooth muscle cells (Boucher et al., 2003) for this purpose, the pathway by
which LRP in macrophages alters the progression of atherosclerosis is not known.
25
1 Introduction
Figure 1.10 Proposed effects of LRP and LRP1b in APP trafficking and processing. LRP is
able to form a complex with APP via Fe65 and enhance its internalization. In the endosomal compartment,
APP is available for processing by BACE and PS-1 which generates both the Aβ peptide and releases the
APP intracellular domain (ICD) into the cytoplasm. While LRP and Aβ are shuttled back to the cell
surface, APP ICD stays associated with Fe65 and, together with Tip60, forms a complex able to suppress
further transcription of LRP. APP binding to LRP1b (possibly by a yet unidentified adapter protein) is not
preferentially endocytosed but stays at the plasma membrane. Here, it is subjected to different processing
events resulting in the release of sAPP which does not contribute to progression of Alzheimer’s.
1.1.6 LRP1b
LRP1b is highly homologous to LRP, except for an additional LA repeat in LRP1b. Addi-
tionally, a splice variant of LRP1b contains a unique exon coding for a 33 amino acid long
insert in the receptor’s cytoplasmic tail (Liu et al., 2000). LRP1b was originally identified as
a putative tumor suppressor which is inactivated in 40% of non-small lung cancer cell lines
(Liu et al., 2000). Later on, mutations in the LRP1b gene were also found to be linked with
several other kinds of cancer (Hirai et al., 2004; Langbein et al., 2002; Pineau et al., 2003;
Sonoda et al., 2004). The mechanisms by which LRP1b interferes with tumor progression
might be based on its ability to impair urokinase receptor regeneration on the cell surface
and inhibit cell migration (Li et al., 2003).
Although human LRP1b expression seems to be widespread with highest levels in brain,
adrenal gland, salivary gland, and testis, the almost exclusive expression site of LRP1b in
mice is the central nervous sytem (Li et al., 2005). In the brain, LRP1b is involved in
development of Alzheimer’s disease, too. An antagonistic effect of LRP1b for LRP-mediated
26
1.1 The LDL receptor family in endocytosis and signaling
pathways was suggested, since LRP1b binds the same ligands as LRP but exhibits a much
slower internalization rate (Liu et al., 2001) (Fig. 1.10). Confirming this hypothesis, it was
shown that the slow endocytosis rate of LRP1b leads to accumulation of APP on the cell
surface together with a reduction of Aβ production (Cam et al., 2004).
1.1.7 Megalin
Megalin is an endocytic receptor which interacts with several signaling pathways by regula-
tion of the availability of the respective extracellular ligands, including BMP4, vitamin D,
and sex hormones.
Expression levels of megalin in the adult organism are highest in the proximal renal tubule
and intestinal epithelium (Mu¨ller et al., 2003), more specifically at the apical surface of
these epithelial borders (Christensen et al., 1995). In the epithelium of the proximal renal
tubule, megalin is responsible for reabsorption of serveral vitamins from the primary urine
(Farese and Herz , 1998). This was first noticed when loss of megalin was shown to result in
increased excretion of 25-hydroxy-vitamin D and vitamin D binding protein (Nykjaer et al.,
1999), leading to vitamin D deficiency and in consequence, bone mineralization defects.
Similar to reuptake of vitamin D/vitamin D binding protein, also vitamin A and vitamin
B12 systemic balance were found to be dependent on megalin function (Christensen et al.,
1999; Moestrup et al., 1996).
Homozygous loss of megalin in the brain leads to impaired bone morphogenic protein 4
(BMP4) signaling, since megalin was shown to bind and deliver BMP4 to the lysosome for
degradation. Therefore, in the absence of megalin, BMP4 accumulates which negatively
regulates sonic hedgehog (Shh) signaling, resulting in holoprosencephaly, a malformation of
the forebrain (Farese and Herz , 1998; Willnow et al., 1996a).
Furthermore, defective sex steroid signaling resulting from megalin deficiency was identified
as a source for malformations in male and female reproductive organs (Hammes et al.,
2005).
More recently, mutations in the megalin gene have been linked to Donnai-Barrow syndrome,
a rare autosomal recessive disorder causing agenesis of the corpus callosum, diaphragmatic
hernia, facial anomalities, ocular anomalies, sensorineural deafness, and cognitive impair-
ment (Kantarci et al., 2007).
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In addition, megalin was also proposed to be involved more directly in signaling pathways in
the proximal renal tubule, since like LRP, it is processed by a metalloproteinase to generate a
soluble extracellular fragment and a membrane-bound C-terminal fragment which can most
likely be further cleaved to release a soluble intracellular domain (Zou et al., 2004). The
potential role of the generated fragment in transcriptional regulation or signaling pathways
is not yet elucidated, however.
1.1.8 MEGF7
Multiple EGF-like domain containing protein 7 (MEGF7) is the most recent member added
to the LDLR family, being identified not until 1998 in a screen for large proteins containing
EGF repeats in the mammalian brain (Nakayama et al., 1998).
MEGF7 deficient mice show developmental defects including most prominently, growth retar-
dation and polysyndactyly, combined with mild craniofacial and tooth abnormalities (John-
son et al., 2005). Polysyndactyly, the fusion and duplication of digits at fore and hind limbs,
is the result of inappropriate digit formation due to disruption of a network of essential sig-
naling pathways including fibroblast growth factors (FGF), BMPs, Wnts, and Shh. Indeed,
MEGF7 was found to modulate these pathways by regulating expression of the respective
signaling proteins (FGF8, BMP2, BMP4, Wnt7a, Shh). This leads to abnormal growth of
the early embryonic limb bud, the major site of MEGF7 expression in the embryo (Johnson
et al., 2005). The essential role of MEGF7 in digit differentiation was confirmed more re-
cently when two new mutations of the gene were found to result in the same phenotype of
polysyndactyly as described for homozygous knockout mice (Simon-Chazottes et al., 2006).
In the nervous system, MEGF7 deficiency manifests in a block of the early development of
neuromuscular junctions (NMJ) in the postsynaptic endplate region of muscles (Weatherbee
et al., 2006). Furthermore, MEGF7 was shown to interact with PSD-95 and influence its
regulation by calmodulin-dependent protein kinase II (CAMKII) (Tian et al., 2006).
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1.2 The Reelin signaling pathway
1.2.1 Physiological significance of the Reelin signal
Reelin is a large glycoprotein of the extracellular matrix (ECM) which is mainly found in
the central nervous system (CNS). Via binding to transmembrane receptors and subsequent
phsophorylation of intracellular proteins, Reelin transmits a signal into neuroblasts of the
developing cerebellum, cerebral cortex, and hippocampus, guiding their migration to their
proper destinations. There, lack of Reelin results in disturbed neuronal layer formation
and general developmental deficits (Fig. 1.11). Its direction-giving role persists to the
postnatal brain, when the Reelin cascade controls migration of neuronal precursors from the
subventricular zone through the rostral migratory stream for the continous supply of the
olfactory bulb (OB) (Hack et al., 2002) and from the subgranular zone to the granule cell
layer in the dentate gyrus (Frotscher et al., 2003). Furthermore, it is involved in synaptic
plasticity (D’Arcangelo, 2005; Weeber et al., 2002) and development of dendrites (Niu et al.,
2004) and dendritic spines (Niu et al., 2008).
Reelin is not restricted to the brain but it can also be detected in the blood stream, liver,
and adrenal gland (Smalheiser et al., 2000), spinal cord (Yip et al., 2004), eyes (Pulido et al.,
2007), lymphatic capillaries (Samama and Boehm, 2005), and in the dental pulp (Buchaille
et al., 2000). Knowledge of the physiological functions of Reelin in these tissues however, is
still scarce. Suggestions include roles for Reelin in nociceptive processing (Akopians et al.,
2008; Villeda et al., 2006), response to injury of the eye and liver (Kobold et al., 2002; Pulido
et al., 2007), peripheral nerve regeneration (Lorenzetto et al., 2008), and lymphangiogenesis
(Samama and Boehm, 2005).
Reelin deficiency in mice leads to motoric defects, most likely arising from problems in
cerebellar development. The main characteristics of this phenotype are ataxia, tremors,
imbalance, and a reeling gait. These deficits were first observed by Douglas Scott Falconer
in 1951 in mice he descriptively named reeler due to their behaviour (Falconer , 1951). The
gene responsible for the reeler phenotype was cloned and identified more than forty years
later (D’Arcangelo et al., 1995).
In men, complete disruption of the Reelin signaling pathway is very rarely observed. Still,
two human disorders have been shown to arise from malfunctioning of this signaling cascade.
Norman-Roberts syndrome, a form of lissencephaly, was first described in 1976 (Norman
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Figure 1.11 Laminar defects in reeler mice. In the reeler brain, layered structures are disorganized and
degenerated. Reelin deficiency is most obvious in the hippocampus (d), cerebellum (e), and cerebral cortex
(f) when compared to the corresponding structures of the wildtype brain (a-c). (Adapted from Trommsdorff
et al., 1999).
et al., 1976) and is characterized by severe cerebellar hypoplasia, cognitive delay, craniofacial
features, and seizures. It is attributed to a mutation in the Reelin gene (Hong et al., 2000)
and is inherited as an autosomal recessive trait.
The second Reelin signaling associated disorder, a subgroup of dysequilibrium syndrome,
arises from disruption of the VLDLR gene (Boycott et al., 2005; Moheb et al., 2008), coding
for one of the Reelin receptors, and is also known as VLDLR-associated cerebellar hypopla-
sia (VLDLR-CH). Although dysequilibrium syndrome was first described in 1973 (Sanner ,
1973), the connection between this condition and VLDL receptor was first identified in 2005
in several individuals of the Hutterite population in the USA and Canada (Boycott et al.,
2005; Glass et al., 2005; Schurig et al., 1981), and a number of Iranian (Moheb et al., 2008)
and Turkish (Ozcelik et al., 2008; Tu¨rkmen et al., 2008) families. Patients present with
ataxia, mental retardation, and occasional seizures. In addition, quadrupedal locomotion
was observed in affected families from Turkey, which however, seems to be a behavioural
adaptation (Tu¨rkmen et al., 2008). Like Norman-Roberts Syndrome, also VLDLR-CH is
inherited in an autsomal recessive manner.
Epigenetic regulation and polymorphisms of the Reelin gene were also implicated in sev-
eral psychological diseases, including autism (reviewed in Fatemi , 2005; Kelemenova and
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Ostatnikova, 2009), bipolar disorder (Guidotti et al., 2000), and schoziphrenia (reviewed in
Fatemi , 2005; Grayson et al., 2006). Furthermore, a strong link between the Reelin pathway
and Alzheimer’s disease was suggested, since Reelin expression and glycosylation is altered
in patients (Botella-Lo´pez et al., 2006) and gene variants correlate with pathogenesis of AD
(Seripa et al., 2008). Furthermore, Reelin was shown to influence tau phosphorylation (Hies-
berger et al., 1999; Ohkubo et al., 2003), affect APP trafficking and processing (Hoe et al.,
2006), and antagonize Aβ effects at the synapse (Durakoglugil et al., 2009).
1.2.2 Components and mechanism of Reelin signaling
Reelin is a large glycoprotein of about 450 kDa which is secreted by specialized cells into
the extracellular matrix. It can act both as a serine protease (Quattrocchi et al., 2002) and
as a signaling molecule in the Reelin pathway.
The structure of the Reelin protein is composed of several modules (see Fig. 1.12). At the
N-terminus, Reelin contains a cleavable signaling peptide (S), followed by a region show-
ing similarity to F-Spondin (SP), and a unique region only found in Reelin to date (H).
This N-terminal part of Reelin has been shown to be essential for Reelin dimerization or
multimerization (Kubo et al., 2002).
The major part of Reelin is composed of 8 consecutive repeats each of which contains two
subdomains (A and B), separated by an EGF-like motif (D’Arcangelo et al., 1995).
Figure 1.12 Schematic representation of the Reelin protein. Reelin comprises a short signal peptide
(S), an F-Spondin homology domain (SP), a unique region (H), eight consecutive Reelin repeats (1-8), and C-
terminal strongly basic region (+). Each Reelin repeat is composed of two subdomains (A and B), separated
by an EGF motif (depicted in blue). (Adapted from Tissir and Goffinet , 2003).
The highly conserved C-terminal region of Reelin (+) contains basic residues and was sug-
gested to be essential for secretion of the protein, since mice with mutant Reelin lacking this
domain (reeler Orleans) accumulate Reelin in the cytoplasm (de Bergeyck et al., 1997). More
recently however, this view was refuted when it was proposed that instead, the C-terminal
region is necessary for efficient downstream signaling by binding tightly to Reelin repeat 8,
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thereby altering its structure and augmenting the interaction with Reelin receptors on the
cell surface (Kohno et al., 2009b; Nakano et al., 2007).
In vivo, Reelin is processed by yet unknown metalloproteinases at two sites between repeats
2 and 3, and 6 and 7 (Lambert De Rouvroit et al., 1999), thereby generating three fragments
(N-R2, R3-6, and R7-8) and two intermediates (N-R6 and R3-8) (Fig. 1.13). The function of
the individual fragments is not entirely clear yet although the central fragment of Reelin (R3-
6) was proposed to be necessary and sufficient for binding to its receptors and stimulation of
the Reelin pathway (Jossin et al., 2004; Yasui et al., 2007). The N-terminal fragment N-R2
was recently proposed to be generated within target cells which have internalized Reelin and
to be subsequently resecreted into the extracellular space. The amount of secreted N-R2
fragment however, does not seem to have any influence on the signaling activity of Reelin
(Hibi and Hattori , 2009).
Figure 1.13 Proteolytic fragments of Reelin. Reelin is processed at two sites at the borders between
repeats 2/3 and 6/7. Single cleavages produce two intermediate fragments, N-R6 and R3-8, while complete
processing generates three final fragments, N-R2, R3-6, and R7-8.
While in vitro, processing of Reelin does not have any effect on or even reduces its signaling
activity (Jossin et al., 2004; Kohno et al., 2009a), it seems to be a crucial step for functional
signaling in cultured embryonic brain slices (Jossin et al., 2007). This contradiction could
be explained by a requirement of Reelin, being anchored to the ECM, to be released by
proteolytic cleavage in order to reach and stimulate target cells. Release would not be
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necessary for neuronal cultures in vitro where all cells are exposed to soluble Reelin and its
fragments (Jossin et al., 2007).
To stimulate the signaling cascade (Fig. 1.14), Reelin has to be available as disulfide-linked
homodimers which are formed by interaction of the N-terminal domains of the proteins (Kubo
et al., 2002). Reelin dimers interact with the extracellular ligand binding domains of two
or more ApoER2 and/or VLDLR molecules (D’Arcangelo et al., 1999). The receptors are
thereby clustered which allows them to induce phosphorylation of the intracellular adapter
protein Dab1 (Strasser et al., 2004) being bound to the NPXY motifs in the receptors’
cytoplasmic tails via its phosphotyrosine binding (PTB) domain (Howell et al., 1999).
Dab1 phosphorylation can occur on five tyrosine residues (Y185, Y198, Y200, Y220, and
Y232) with Y198 and Y220 seeming to be the major phosphorylation sites responding to
Reelin stimulation (Keshvara et al., 2001). Involvement of Y185 and Y232 remains con-
troversial (Feng and Cooper , 2009; Keshvara et al., 2001; Morimura and Ogawa, 2009).
Recently, it was disparately proposed that distinct phosphorylated tyrosine residues might
either be important for different downstream signaling events mediated by Dab1 (Morimura
and Ogawa, 2009) or might be able to compensate for each other (Feng and Cooper , 2009).
As a prerequisite for tyrosine phosphorylation however, Dab1 has to be serine/threonine
phosphorylated by cyclin-dependent kinase 5 (Cdk5) which acts independently of Reelin
signaling (Keshvara et al., 2002). Only in this state, Dab1 is a substrate for tyrosine phos-
phorylation by members of the Src family of kinases (SFK). The main kinase for Dab1 was
shown to be Fyn although also Src and, to a lesser extent, Yes act on Dab1 in response to
Reelin (Arnaud et al., 2003b; Kuo et al., 2005).
The respective kinase might be recruited to the signaling complex by interaction of Reelin
with a co-receptor. Members of the integrin family of adhesion molecules mediating interac-
tions between neurons and glia cells (Anton et al., 1999), would be possible candidates for
this. α3β1-integrin is able to associate with SFKs at its intracellular tail (Schwartz , 2001)
and Reelin at the extracellular domain (Dulabon et al., 2000). It was therefore proposed to
be recruited to ApoER2/VLDLR-bound Dab1 upon Reelin stimulation, thereby contribut-
ing to Dab1 phosphorylation (Gupta et al., 2002; Schmid et al., 2005). As it was shown
in our lab however, clustering of ApoER2 or VLDLR by antibodies against the respective
ligand binding domains is sufficient for Dab1 phosphorylation (Strasser et al., 2004). So, at
least the primary Reelin signaling event is independent of a potential co-receptor.
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The initial components of the pathway seem to constitute a linear signal transmission, since
mice lacking either Reelin, ApoER2 and VLDLR, or Dab1 show a similar phenotype. This
was observed in naturally occuring mutants, including reeler, and scrambler and yotari
mice, both lacking functional Dab1 (Sheldon et al., 1997), in knockout mice for ApoER2 and
VLDLR (Trommsdorff et al., 1999), or Dab1 (Howell et al., 1997), and in mice expressing a
mutated phosphorylation-incompetent Dab1 protein (Howell et al., 2000).
Figure 1.14 Transmission of the Reelin signal. Reelin bind to its receptors ApoER2 and VLDLR
which causes tyrosine phosphorylation of Dab1 by Src family kinases (SFK). Phosphorylated Dab1 has sev-
eral downstream targets involved in microtubule rearrangement (PI3-K pathway, Lis1), regulation of actin
polymerization (N-WASP, Nckβ, Crk), cell survival (BAD), dendritic development (mTor), and gene expres-
sion (Notch1). Dab1 itself is ubiquitinated and degraded by the proteasome upon activation of the signaling
pathway.
Signaling downstream of Dab1 is more diverse and less well characterized than the initial
steps of the cascade. One pathway is based on interaction of phosphorylated Dab1 with
phosphatidylinositol-3-kinase (PI3-K), leading to activation of protein kinase B (PKB)/Akt,
thereby blocking action of glycogen synthase kinase 3β(GSK3β) (Beffert et al., 2002; Bock
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et al., 2003). This results in reduced phosphorylation of the microtubule-associated protein
tau (Beffert et al., 2002; Ohkubo et al., 2003). Another downstream target of PKB/Akt is
mammalian target of rapamycin (mTor) which was also reported to be regulated in response
to Reelin signaling. This branch of the signaling cascade seems to be of special importance
for the role of Reelin in dendritic development (Jossin and Goffinet , 2007). Furthermore,
Reelin-induced PI3-K/Akt signaling might participate in cell survival via phosphorylation
of Bcl-2/Bcl-XL associated death promoter (BAD) (Ohkubo et al., 2007). Obviously, Reelin
stimulation might as well influence other targets of the PI3-K pathway, although these effects
are not clarified yet.
Dab1 was also shown to regulate neuronal Wiscott-Aldrich Syndrome protein (N-WASP),
leading to activation of actin-related protein 2/3 (Arp2/3) complex and actin polymerization
at the leading edge of migrating neuroblasts (Winder , 2004). This enables the formation of
filopodia and cellular motility.
Moreover, as it was recently shown, the Reelin pathway seems to employ Notch signaling
for proper neuronal migration in the developing cortex (Hashimoto-Torii et al., 2008). Dab1
which co-immunoprecipitates with Notch-1 and Notch intracellular domain (NICD, the ac-
tivated form of the receptor), likely is the signal mediator here, too (Keilani and Sugaya,
2008).
Other interaction partners of tyrosine-phosphorylated Dab1 are lissencephaly 1 (Lis1) (As-
sadi et al., 2003), Nck (noncatalytic region of tyrosine kinase) adapter protein (Nckβ)
(Pramatarova et al., 2003), and Crk family members (Ballif et al., 2004; Chen et al., 2004;
Huang et al., 2004). The common characteristic of these signaling targets is their involvment
in cytoskeletal rearrangements of both microtubuli and actin filaments, and cell migration.
Dab1 itself is subjected to ubiquitination and subsequent proteasomal degradation upon
Reelin-induced phosphorylation as a feedback mechanism (Arnaud et al., 2003a). Ubiquiti-
nation is carried out by an E3 ubiquitin ligase. Selection of phosphorylated Dab1 relies on
the ubiquitinase’s component Cullin 5 (Cul5) which only binds to Dab1 if it is phosphory-
lated on Y198 (Feng et al., 2007). In the absence of Cul5, Dab1 accumulates, resulting in
excess migration of neuroblasts in the cortical plate (Feng et al., 2007).
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1.2.3 Reelin signaling in neocortical development
The mammalian neocortex is the tissue best studied in terms of Reelin signaling. The
neocortex is the evolutionary youngest part of the brain, constituting the outermost layer of
the cerebral cortex.
Horizontally, it is organized in several distinct regions being specialized in complex processes
like memory, learning, and sensory functions. The vertical structure reveals six cellular lay-
ers, composed of pyramidal neurons, with different morphologies and functions. These neu-
ronal layers are built by sequential radial migration of neuroblasts from the germinal center,
the ventricular zone (VZ) along glial fibers to the pial surface of the brain. This happens in
an ”inside-out-manner”, meaning that earliest born neurons populate the innermost layers
whereas later born cells settle in more superficial layers.
Figure 1.15 Development of the six-layered structure of the neocortex. Cortical postmitotic neu-
rons start migration from the ventricular zone (VZ) to the pial surface (PS) of the cortex at E11, establishing
the preplate (PP). At E13, this structure is split by the second wave of neurons into the subplate (SP) and
marginal zone (MZ). Further neuronal waves pass the intermediate zone (IZ) by glia-guided migration and
populate the cortical plate (CP) in an inside-out pattern, meaning that each batch of neurons bypasses all
earlier layers to settle above them, just underneath the MZ. At E18, when the cortical plate is established, the
subplate degenerates, leaving behind the final six-layered structure of the neocortex. (Adapted from Andrade
et al., 2007).
In the mouse, this process is initiated at embryonic day 11 (E11) when the first batch of
neuroblasts starts migrating and form the so-called preplate (PP), a temporary layer of the
developing cortex containing Cajal-Retzius cells which have been shown to be the Reelin
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secreting cells in the mammalian cortex (D’Arcangelo et al., 1997). The second wave of
neuoblasts starts migration at E13 and splits the preplate into the marginal zone (MZ) with
Cajal-Retzius neurons and the subplate (SP). These cells constitute the first layer of the
new cortical plate. The following neuronal waves have to pass not only the subplate but also
the earlier neuronal layers in order to reach their proper positions just beneath the marginal
zone. Once all six layers have been established around E18, the subplate degenerates (Gupta
et al., 2002) (Fig. 1.15) and the remaining structure persists into adulthood.
In the Reelin deficient brain, migrating neuroblasts are unable to traverse the existing layers
of older neurons. In particular, even splitting of the preplate does not occur, leaving a
structure called the superplate (SPP). Later on, this defect results in an inverted ”outside-
in” and disorganized layering of the cortical plate (Gupta et al., 2002) (Fig. 1.16).
Figure 1.16 Developmental defect in the reeler neocortex. In reeler mice, migrating neuroblasts
are unable to pass existing neuronal layers. This results in defective preplate splitting which leaves the
double-layered so-called superplate (SPP) to reside beneath the MZ. Consequently, later neuronal waves are
equally unable to traverse their predecessors, leading to an inverted cortical layering since later neurons settle
beneath earlier ones. (Adapted from Andrade et al., 2007).
Several hypotheses concerning the actual role of Reelin in this layering mechanism have
been discussed. Reelin was proposed to act as a chemokine, to constitute a repellant cue for
migrating neuroblasts (Schiffmann et al., 1997), to transmit a stop signal to cells which have
reached their final destination (Frotscher , 1997), or to facilitate dissociation of neuroblasts
from radial glia (Dulabon et al., 2000).
The most conclusive integrative model for Reelin action was presented recently (Cooper ,
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2008). This ”detach and go” model is based on the occurance of two distinct modes of
migration occuring during formation of the cortical plate (Nadarajah et al., 2001).
Glia-giuded locomotion describes the movement of the entire neuronal cell along radial glial
fibers which constitute a scaffold for the migrating neuroblast. Somal translocation is a
glia-independent mechanism. Here, the migrating cell first extends its leading edge towards
the marginal zone and, after encountering Reelin, shortens its process which is anchored to
the MZ, in order to pull the cell soma through the preexisting neuronal layers (Fig. 1.17).
During corticogenesis, somal translocation seems to be preferentially used by neuroblasts of
early waves, whereas the majority of later neurons who have to bypass greater distances and
a growing number of neuronal layers, employs locomotion (Nadarajah et al., 2003).
Figure 1.17 Two modes of neuronal migration.
Radial migration of neurons occurs by two different mech-
anisms. During somal translocation, the cell pulls its
soma along its previously extended leading edge which
is attached to the MZ. Cells migrating by locomotion use
radial glial fibers as a scaffold and move the entire cell at
once. (Adapted from Andrade et al., 2007).
The ”detach and go” model states that when the extended leading processes of the first waves
of migrating neurons reach the MZ, Reelin initiates somal translocation, either for splitting
the preplate or for transition through the subplate. Later neurons use locomotion along glia
fibers to reach the MZ and encounter Reelin. There, Reelin induces detachment from radial
glia and again somal translocation to enable these neurons to bypass preexisting layers. In the
absence of Reelin, the failure of this mechanism would therefore lead to an unsplit preplate.
Later neuronal waves would still be able to migrate along radial glial fibres but would get
stuck beneath the first neuronal layer, unable to initiate somal translocation (Cooper , 2008)
(Fig. 1.18). These defects are in accordance with the observed reeler phenotype which
strongly supports this model for Reelin action.
The action of Reelin might be extended by additional aspects facilitating migration of neu-
roblasts. First, Reelin might use its serine protease activity (Quattrocchi et al., 2002) to
affect cellular adhesion and thereby assist in the migration process.
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Figure 1.18 The detach and go model. According to this model, early neurons (1, 2) use somal
translocation to reach their destined layer when they encounter Reelin in the marginal zone. Later neurons
(3-6) overcome the distance to the MZ by glia-guided locomotion. Upon Reelin binding, they detach from
the glial fibers and bypass the earlier layers by somal translocation. In Reelin deficient brains, early neurons
are not able to translocate while later neurons still travel along the glial fibers but fail to detach and pass the
pre-existing layers. This leads to an inverted and disorganized laminar structure. (Modified from Cooper ,
2008).
Second, since it was shown to interact with α3β1-integrin, Reelin could further enhance
dissociation of neurons from radial glia by removal of α3β1-integrin from the cell surface via
endocytosis (Dulabon et al., 2000).
Third, Reelin was reported to induce phosphorylation of n-cofilin, a protein involved in
actin disassembly, which leads to stabilzation of the cytoskeleton. This might constitute a
mechanism for anchoring the leading processes of migrating neuroblasts to the MZ when
they encounter Reelin (Chai et al., 2009).
Interestingly, n-cofilin phosphorylation requires Reelin, ApoER2, Dab1, PI3K, and SFKs but
not VLDLR (Chai et al., 2009). Previously, it was reported that late migrating neuroblasts
in the neocortex depend only on ApoER2 but not VLDLR (Hack et al., 2007), leading to
the assumption that these neurons of the outer cortical layers may especially need n-cofilin-
induced stabilization of their leading edge, possibly for giving the orientation needed for
somal translocation (Chai et al., 2009).
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2 Aims of this study
The Reelin signal can be transmitted into target cells by both ApoER2 and VLDLR. Both
receptors are able to phosphorylate the primary Reelin target, Dab1, with equal efficien-
cies. This explains why these receptors can, to a large extent, compensate for each other
as corroborated by analysis of single receptor knockout mice. Only loss of both ApoER2
and VLDLR results in a phenotype which is also observed in reeler mice, lacking functional
Reelin. Nevertheless, loss of either one of the Reelin receptors leads to distinct phenotypes
in mice. Both single receptor knockouts show disorganized cortical layers. However, while
the reeler -typical inversion of cortical lamination can be found in ApoER2 but not VLDLR
knockout mice, loss of VLDLR leads to overmigration of cortical neuroblasts (Hack et al.,
2007). Moreover, VLDLR seems to be essential for the structural development of the cere-
bellum, whereas the primary role of ApoER2 lies in cortical lamination (Trommsdorff et al.,
1999).
Observation of these differences led to the question which structural and functional features
of ApoER2 and VLDLR discriminate them and specify their distinct function(s). Since
initiation of the signaling cascade does not seem to be influenced by the type of receptor
mediating it, this study aimed at the detailed analysis of the fate of ApoER2 and VLDLR
after binding of Reelin and Dab1 phosphorylation. As it was previously shown, ApoER2 and
VLDLR reside in different microdomains of the plasma membrane. Based on this finding,
endocytotic behaviour, intracellular trafficking, degradation, and processing of both repetors
should be closely investigated and compared here. In addition, chimeric receptors built of
ApoER2 and VLDLR domains and fractionation of plasma membrane microdomains should
be used to link differences between the receptors to structural features or differential sorting
on the cell surface.
41

3 Results and Discussion
3.1 Differential functions of ApoER2 and VLDL receptor in Reelin
signaling
Duit S, Mayer H, Blake SM, Schneider WJ, and Nimpf J. Differential functions of ApoER2
and very low density lipoprotein receptor in Reelin signaling depend on differential sorting
of the receptors. J Biol Chem, 285(7): 4896-908, 2010
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ApoER2 and very low density lipoprotein (VLDL) receptor
transmit the Reelin signal into target cells of the central nervous
system. To a certain extent, both receptors can compensate for
each other, and only the loss of both receptors results in the
reeler phenotype, which is characterized by a gross defect in the
architecture of laminated brain structures. Nevertheless, both
receptors also have specific distinct functions, as corroborated
by analyses of the subtle phenotypes displayed in mice lacking
either ApoER2 or VLDL receptor. The differences in their func-
tion(s), however, have not been defined at the cellular level.
Here, using a panel of chimeric receptors, we demonstrate that
endocytosis of Reelin and the fate of the individual receptors
upon stimulation are linked to their specific sorting to raft ver-
sus non-raft domains of the plasma membrane. VLDL receptor
residing in thenon-raft domain endocytoses anddestinesReelin
for degradation via the clathrin-coated pit/clathrin-coated ves-
icle/endosome pathway without being degraded to a significant
extent. Binding of Reelin to ApoER2, a resident of rafts, leads to
the productionof specific receptor fragmentswith specific func-
tions of their own and to degradation of ApoER2 via lysosomes.
These features contribute to a receptor-specific fine tuning
of the Reelin signal, leading to a novel model that emphasizes
negative feedback loops specifically mediated by ApoER2 and
VLDL receptor, respectively.
Defective Reelin signaling causes lamination defects inmany
areas of the cerebral cortex, hippocampus, and cerebellum
(1, 2). The major abnormality in the cortex arises during
embryogenesis from the inability of radially migrating neu-
rons to invade and split the preplate. These neurons settle
beneath the preplate, which is shifted toward the pial sur-
face, where it forms a “superplate” in affected animals. Con-
sequently, later born neurons cannot bypass earlier neurons
that have settled beneath the superplate so that consecutive
waves of neurons generated in the subventricular zone and
migrating outwards establish a pattern of inverted neuronal
layers. The role of Reelin in the correct lamination of certain
brain structures was recently compiled in the “detach and
go” model (3), where Reelin was proposed to promote
detachment of migrating neurons from glial fibers and their
translocation to the outermost area of the developing cortical
plate. Despite recent progress in understanding molecular
events in the Reelin signaling pathway (reviewed in Refs. 4 and
5), our knowledge about themodulation of the initial signal and
downstream events guiding migration and positioning of neu-
rons or modulating other processes like dendrite development
is still scarce (6, 7). Proposed mechanisms involve Lis1 (8),
Nck (9), and differential modulation of phosphatidylinositol
3-kinase-downstream pathways employing mTOR or GSK3
(10). The key events indispensable for triggering these path-
ways are binding of Reelin to ApoER2 and VLDL2 receptor
(VLDLR) and subsequent phosphorylation of Dab1. Obviously,
Reelin-mediated receptor clustering triggers tyrosine phosphor-
ylation of Dab1 (11). This event, however, does not seem to be
sufficient to evoke the full Reelin signal, because anti-receptor
antibodies that trigger Dab1 phosphorylation by receptor clus-
tering do not rescue the reeler phenotype in brain slice cultures
(12). In addition, thrombospondin 1, which is another func-
tional ligand for ApoER2 and VLDLR in the brain, promotes
Dab1 phosphorylation without eliciting the canonical Reelin
signaling pathway (13).
Dab1phosphorylation ismediatedbymembersof theSrc family
of kinases (14–16). Mice lacking both Fyn and Src develop a phe-
notype similar to that of the Dab1-deficient scrambler mice
(17). Dab1 binds to the NFDNPXY sequence motif present in
the cytosolic domains of ApoER2 and VLDLR (18). This
domain is indispensable for Reelin signaling, sincemice lacking
VLDLR and carrying mutant alleles for ApoER2 coding for an
altered NFDNPVY motif that does not bind Dab1 develop a
reeler phenotype (19). This domain is also present in other
members of the LDL receptor gene family, such as LDL recep-
tor, LRP1, and LRP2 (20), and plays a key role in clathrin-me-
diated endocytosis of these receptors. In a Dab1-overexpress-
ing cell model system, Dab1 decreases the endocytosis rate of
the LDL receptor by interferingwith the formation of the endo-
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chen Forschung, FWF,” Austria, Grants P16872-B09 and P19611-B09 and
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cytosis complex (21). However, because Dab1 is brain-specific,
the interaction with LDL receptor, LRP1, and LRP2 and the
interference with endocytosis of these receptors most likely are
not of physiological relevance.Our own studies and others have
demonstrated that ApoER2 associates with lipid rafts, whereas
VLDLR is strictly excluded from these microdomains (22–24).
Despite its raft association, ApoER2 is endocytosed via the
clathrin-mediated process, apparently through its association
with Dab2 (22). It is still unclear, however, how important
endocytosis of ApoER2 and VLDLR is in Reelin signaling.
With the identification of ApoER2 and VLDLR as functional
Reelin receptors, it became evident that both receptors can
compensate for each other to a certain extent, since only the
lack of both receptors causes the reeler phenotype (25). Loss of
ApoER2orVLDLRalone causes subtle but distinguishable phe-
notypes, pointing to VLDLR being more important for the
development of the cerebellum and ApoER2 for lamination of
the cortex. This factwas recently corroborated by detailed stud-
ies on the divergent roles of ApoER2 and VLDLR in the migra-
tion of cortical neurons (26), which demonstrated that ApoER2
is indispensable for the correctmigration of late generated neu-
rons,whereas theVLDLR-mediatedReelin signal prevents neu-
rons from entering the marginal zone.
Because both receptors mediate Dab1 phosphorylation, the
question of the molecular substrate for their individual func-
tions arises. Using chimeric receptor constructs and a fibroblast
model system, we now demonstrate that endocytosis and cellu-
lar trafficking differ between ApoER2 and VLDLR and relate to
raft versus non-raft localization of these receptors.
EXPERIMENTAL PROCEDURES
Cell Culture and Preparation of Conditioned Media—NIH
3T3 and 293 HEK cells were cultivated in Dulbecco’s modified
Eagle’s medium (DMEM; Invitrogen) supplemented with
10% fetal calf serum (Invitrogen), and penicillin/streptomycin
(Invitrogen) at 37 °C and 7.5% CO2. Stable NIH 3T3-based cell
lines expressing murine ApoER2 harboring LA repeats 1–3, 7,
and 8 and containing the proline-rich cytoplasmic insert (3T3
A), murine VLDLR lacking theO-linked sugar domain (3T3V),
or either receptor and murine Dab1 (3T3 A/D and 3T3 V/D)
(23) were kept under puromycin selection (0.75 g/ml). Stable
cell lines expressing chimeric receptors were generated as
described for 3T3 A and 3T3 V (23) and were grown under the
same conditions. 24 h before the experiment, puromycin-resis-
tant cells were switched to growthmedium lacking puromycin.
Reelin-expressing 293 HEK cells were cultivated and used for
production of Reelin conditioned medium (RCM) as described
before (27). Mock conditioned medium (MCM) was prepared
from untransfected 293 HEK cells using the same procedure.
Primary rat neuronal cultures were obtained from embryonic
day 16.5 rat embryonic brains and were kept in DMEM/F-12
(Invitrogen) containing B27 supplement (Invitrogen) and pen-
icillin/streptomycin at 37 °C and 5% CO2 for 72 h before use as
described (11). Transient transfection of 3T3 was done using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
protocol.
Cloning of Chimeric Receptors—The following primers were
used for generation of chimeric receptor constructs. VLDLR
and ApoER2 primer pairs, spanning the respective full-length
murine cDNAs, each containing an EcoRI restriction site
(underlined), were as follows: VLDLR sense primer (primer 1)
(5-CGG AAT TCA TGG GCA CGT CCG CGC GC-3),
VLDLR antisense primer (primer 2) (5-ATG AAT TCA AGC
CAG ATC ATC ATC TGT GCT TAC-3), ApoER2 sense
primer (primer 3) (5-ATG AAT TCA TGG GCC GCC CAG
AAC TGG-3), and ApoER2 antisense primer (primer 4) (5-
ATG AAT TCT CAG GGC AGT CCA TCA TCT TC-3).
ApoER2-VLDLR chimeric primers, annealing to ApoER2 at
their 5 region (shown in italic type) and to VLDLR at their 3
region (underlined) were as follows: sense primer (primer 5)
(5-GGT ACC TCA TCT GGA GGA ATT GGC AAC-3) and
antisense primer (primer 6) (5-CGCTTCCAGTTCCTCCAC
ATC AAG TAG CC-3), recognizing the junction of trans-
membrane and intracellular domain, and sense primer (primer
9) (5-CAACAGTCACCGCTGCTGCTGCCTGGG-3) and
antisense primer (primer 10) (5-CCC AAT GAC TGA AGT
CCC TTT TGG GGG AAC-3), recognizing the junction of
extracellular and transmembrane domain. VLDLR-ApoER2
chimeric primers, annealing to VLDLR at their 5 region
(underlined) and to ApoER2 at their 3 region (italic type) were
as follows: sense primer (primer 7) (5-GGC TAC TTG ATG
TGG AGG AAC TGG AAG CG-3) and antisense primer
(primer 8) (5-GTTGCCAATTCCTCCAGATGAGGTAAC
CAC-3), recognizing the junction of transmembrane and
intracellular domain, and sense primer (primer 11) (5-CCA
AAA GGG ACT TCA GTC ATT GGG GTC ATC GTG C-3)
and antisense primer (primer 12) (5-GAT GGC CCA GGC
AGC AGC AGC GGT GAC TGT TGA GC-3), recognizing the
junction of extracellular and transmembrane domain.
For the first round of PCR amplification, fragments of
ApoER2 and VLDLR were amplified from pMSCVpuro-
ApoER2 and pMSCVpuro-VLDLR (23), using the following
primers: primers 1 and 10 for VLDLR extracellular domain,
primers 3 and 12 for ApoER2 extracellular domain, primers 1
and 6 for VLDLR extracellular and transmembrane domain,
primers 3 and 8 for ApoER2 extracellular and transmembrane
domain, primers 9 and 2 for VLDLR transmembrane and intra-
cellular domain, primers 11 and 4 for ApoER2 transmembrane
and intracellular domain, primers 5 and 2 for VLDLR intracel-
lular domain, and primers 7 and 4 for ApoER2 intracellular
domain. The obtained fragments were purified and used as
templates for another round of PCR amplification. Fragments
harboring the VLDLR extracellular and transmembrane do-
main were mixed with fragments harboring the ApoER2 intra-
cellular domain and vice versa, and fragments harboring the
VLDLR extracellular domain were mixed with fragments har-
boring the ApoER2 transmembrane and intracellular domain
and vice versa. Primers used for amplification were primers 1
and 4 for the VVA and VAA constructs and primers 3 and 2
for the AAV and AVV constructs. The PCR products
obtained in this second PCR amplification step were cloned
into the pMSCVpuro backbone using the EcoRI restriction
site.
Antibodies—Antibodies against ApoER2 were Ab 186, raised
against the entire ligand-bindingdomain (11);Ab220, raised against
the first ligand-binding repeat (28); and Ab 20, raised against the
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cytoplasmic tail (29). The ligand-binding domain of VLDLR
was detected using Ab 74, which was raised in rabbits using a
maltose-binding protein fusion protein containing the first
ligand binding repeat of VLDLR. Ab 187 (11) was used for
detection of VLDLR in immunofluorescence assays. For immu-
noprecipitation of Dab1, Ab 48 andAb 54 (11) against the short
splice variant ofmurineDab1were used.Mouse anti-Dab1 (D4)
and mouse anti-Reelin (G10) antibodies were kind gifts of
Andre Goffinet (University of Louvain, Belgium). Mouse anti-
Lis1 was obtained from Orly Reiner (Weizmann Institute
of Science, Rehovot, Israel). The following antibodies were
purchased from the indicated sources: mouse anti-VLDLR
(6A6) and mouse anti-phosphotyrosine (PY99), Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA); mouse anti-HA (HA.11),
Covance; mouse anti-clathrin heavy chain and rabbit anti-
Caveolin, BD Transduction Laboratories; rabbit anti-early
endosomal antigen 1, Affinity BioReagents; secondary HRP-
conjugated anti-mouse and anti-rabbit antibodies, Jackson
ImmunoResearch; Alexa Fluor 488 goat anti-mouse and Alexa
Fluor 594 goat anti-rabbit, Molecular Probes.
Preparation of Cell Extracts, SDS-PAGE, and Western
Blotting—Cells were washed twice with ice-cold PBS and
lysed in Hunt buffer (20 mM Tris, pH 8.0, 100 mM NaCl,
0.5% Nonidet P-40, 1 mM EDTA) supplemented with protein-
ase inhibitor mix (CompleteTM, Roche Applied Science). Cell
debris was removed by centrifugation for 5 min at 20,000  g.
Proteins were separated by reducing SDS-PAGE and trans-
ferred onto nitrocellulose membranes by semidry blotting.
Membranes were blocked in PBS containing 0.1% Tween 20
and either 5% bovine serum albumin or 5% nonfat dry milk and
incubated with primary and HRP-conjugated secondary anti-
bodies. For detection, enhanced chemiluminescence solution
(Pierce) was used. For quantification of Western blot results,
integrated optical density (IOD) values of the bands were cal-
culated using Gel-Pro analyzer software (Media Cybernetics)
and normalized to IOD of the loading control. For ligand blots,
cell extracts were separated by non-reducing SDS-PAGE and
Western blotting, and membranes were blocked in TBS con-
taining 5% bovine serum albumin and 2 mM CaCl2 and incu-
batedwith RCMdilutedwithOpti-MEM (1:2) containing 2mM
CaCl2 for 2 h before incubationwith primary (G10) and second-
ary antibodies.
Reelin Uptake and Degradation Assay—NIH 3T3 cells ex-
pressing ApoER2 or VLDLR were precooled at 4 °C for 30 min
and incubated with RCM at 4 °C for 1 h to allow for Reelin
binding to the cells. After extensive washing with TBS, cells
were covered with Opti-MEM (Invitrogen) and shifted to a
37 °C water bath. After the indicated periods, cell extracts were
prepared using Hunt buffer and analyzed by Western blotting.
Relative Reelin amounts were calculated from IOD values.
Dab1 Phosphorylation Assay—Cells expressing Dab1 and
one of the receptors were starved for 1 h in plain DMEM and
incubated for 1 h with RCM or MCM. Cell extracts were pre-
pared in Hunt buffer containing protease inhibitor mix and
phosphatase inhibitors (50 mM NaF and 2 mM Na3VO4) and
used for immunoprecipitation. Extracts were incubated with
anti-Dab1 antiserum overnight at 4 °C, 40 l of a protein
A-Sepharose bead slurry (Zymed Laboratories Inc.) were
added, and samples were incubated for 1 h at 4 °C again. Beads
were collected by centrifugation at 500  g for 1 min and
washed three times using Hunt buffer. Samples were analyzed
by Western blotting.
Receptor Degradation and Fragmentation Assays—To ana-
lyze degradation and secretase-mediated fragmentation of
ApoER2, receptor-expressing cells were starved for 1 h in plain
DMEM or DMEM containing 20 g/ml cycloheximide and
incubated for 4 or 6 h with medium containing cycloheximide
and the indicated ligands and supplements. Cell extracts were
prepared in Hunt buffer and analyzed by Western blotting.
Isolation of Caveolin-rich Light Membranes (CLM)—CLM
were prepared from stable NIH 3T3 fibroblasts grown to con-
fluence in 15-cm dishes or from WT mouse embryonic brains
isolated at embryonic day 15. All procedureswere carried out at
4 °C. Briefly, cells were washed with TBS and pelleted by cen-
trifugation (5 min, 1400  g). The supernatant was removed,
and cells were solubilized in TBS containing 2%Brij 78P (Fluka)
and CompleteTM protease inhibitors (Roche Applied Science)
by passaging the cells 10 times through a 23-gauge needle. Cell
debris was removed by centrifugation (10 min, 21,000 g) and
the lysate (0.6ml) wasmixedwith 0.6ml of 90% (w/v) sucrose in
MBS (MES-buffered saline; 25 mMMES, pH 6.5, 150mMNaCl)
and transferred to an ultracentrifuge tube. A discontinuous
sucrose gradient was formed above the homogenate by adding
2.5 ml of 35% (w/v) sucrose in MBS, followed by 0.6 ml of 5%
(w/v) sucrose in MBS. After centrifugation at 160,000  g for
20 h in a Beckman SW60Ti rotor at 4 °C, 0.44-ml fractions were
collected from the top of the tube. Fraction 2 at the interface
between the 5 and 35% sucrose boundaries was designated the
CLM fraction.
Preparation of Clathrin-coated Vesicles—Coated vesicles
were prepared from NIH 3T3 cells expressing either receptor
grown to near confluence or primary rat neurons cultured for
72 h using a 2H2O, 8% sucrose gradient (30). Cells were washed
twice with PBS and once with MES buffer (100 mM MES, pH
6.5, 1 mM EGTA, 0.5 mM MgCl2, 3 mM NaN3, CompleteTM
proteinase inhibitor mixture). All steps were carried out at
4 °C. Cells were scraped in MES buffer and homogenized
using a Potter tissue grinder. The homogenate was centri-
fuged at 5000 g for 5min. The pellet was resuspended inMES
buffer and centrifuged at 5000 g for 5 min. The supernatants
from the two centrifugationswere combined and centrifuged at
100,000 g for 60min. The resulting pellet was resuspended in
MES buffer and centrifuged at 10,000  g for 10 min. The
resulting pellet was resuspended in MES buffer again, and the
centrifugation was repeated. The supernatants from the two
centrifugation steps were combined and centrifuged at
100,000 g for 60 min. The pellet was resuspended in 1 ml of
MES buffer and centrifuged at 10,000 g for 10min; the result-
ing pellet was again resuspended using 1 ml of MES buffer and
centrifuged at 10,000  g for 10 min. The combined superna-
tants were loaded on the top of 2 ml of 8% sucrose in 2H2O and
centrifuged at 80,000  g for 2 h. The pellet, resuspended in
MES buffer, was centrifuged at 20,000  g for 10 min. The
supernatant was recovered and designated as clathrin-coated
vesicle (CCV) fraction. Protein concentration was determined
using theCoomassie Plus protein assay reagent (Pierce) accord-
Distinct Functions of ApoER2 and VLDL Receptor
4898 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 7•FEBRUARY 12, 2010
ing to the manufacturer’s protocol, and equal protein amounts
of cell lysates andCCVwere subjected to SDS-PAGE andWest-
ern blotting.
Immunofluorescence Assays and Microscopy—Sterile glass
coverslips were coated with 40 g/ml poly-L-lysine in PBS for
1 h at room temperature. NIH 3T3 cells expressing ApoER2
or VLDLR were grown on the coverslips for 24 h using stand-
ard fibroblast growth medium. Cells were cooled to 4 °C,
washed with ice-cold PBS, and overlaid with RCM. After 1 h
of incubation, RCM was removed, and cells were washed and
incubated with Opti-MEM at either 4 or 37 °C for 10 min. Sub-
sequently, cells were washed and fixed with 4% paraformalde-
hyde fixative. Fixed cells were washed with PBS containing 100
mM glycine and incubated with 0.1% Triton X-100 in PBS for 2
min to permeabilize the plasma membrane. Cells were washed
again with PBS, blocked for 30 min with blocking solution (1%
bovine serum albumin in phosphate-buffered saline) at room
temperature, and incubated with primary and secondary anti-
bodies diluted in blocking solution for 1 h each. Coverslipswere
washed again and mounted on glass slides using DAKO fluo-
rescent mounting medium (Dako Corp.). Slides were analyzed
using a confocal fluorescence microscope (laser-scanning
microscope 510, Zeiss) and the corresponding software (Zeiss
LSM Image Browser). Antibodies used for detection were Ab
186 for ApoER2, Ab 187 for VLDLR, G10 for Reelin, anti-early
endosomal antigen 1, and secondary Alexa Fluor-coupled anti-
mouse and anti-rabbit antibodies.
RESULTS
Expression and Subcellular Sorting of Chimeric Receptors—
We have recently demonstrated that (i) ApoER2 and VLDLR
reside in distinct subdomains of the plasma membrane and (ii)
independently of this localization, both receptors mediate Ree-
lin-inducedDab1 phosphorylation (23). Thus, we reasoned that
recently unraveled functional differences of ApoER2 and
VLDLR in migration of cortical neurons (26) could be due to
differences in ligand endocytosis and intracellular trafficking of
the receptors. Such differences might be caused either by dif-
ferential sorting of the receptors to raft versusnon-raft domains
or by intrinsic properties of the receptor molecules indepen-
dent of their sorting. To distinguish between these possibilities,
we constructed a panel of chimeric receptors by swapping the
respective intracellular, transmembrane (TM), and extracellu-
lar domains as detailed in Fig. 1A. The resulting chimeric recep-
tors termed VVA, AAV, VAA, and AVV (V, derived from
VLDLR;A, derived fromApoER2; in the order from left to right:
extracellular domain, transmembrane, cytoplasmic domain),
were expressed in 3T3 mouse fibroblasts and tested for func-
tionality. As demonstrated in supplemental Fig. 1A, all con-
structs were expressed at comparable levels and were recog-
nized by the appropriate antibodies (corresponding epitopes
for the antibodies used are indicated in Fig. 1A). The faint dou-
ble band produced by Ab 74 in cells expressing constructs not
containing the extracellular domain of VLDLR must be due to
cross-reactivity with an unrelated protein because it is also
present in mock-transfected 3T3 cells. Furthermore, all con-
structs containing the extracellular domain derived from
ApoER2 produce a double band, which is characteristic for
ApoER2 and represents the precursor and the mature form of
the receptor (23). All chimeric receptors bind Reelin, as tested
by ligand blotting (supplemental Fig. 1B), and 3T3 fibroblasts
expressing Dab1 (23), and any one of the chimeric receptors
respond to Reelinwith robustDab1 phosphorylation as theWT
receptors do (supplemental Fig. 1C). Next, we compared the
subcellular localization of the chimeras with those of the WT
receptors by separating the cell membranes into CLM and
heavymembrane fractions containing ERmembranes and non-
raft fractions of the plasma membrane (non-caveolae mem-
branes (NCM)) as described (23). As demonstrated previously
in fibroblasts (23), mature ApoER2 is predominantly present in
the CLM fraction, characterized by the presence of caveolin,
whereas the immature form of ApoER2 (present in the ER) and
VLDLR are exclusively found in the heavy non-raft membrane
fraction (Fig. 1B). This particular subcellular distribution is not
a specific effect seen in fibroblasts but is also evident in vivo
because the receptors follow the same distribution in mem-
branes prepared from embryonic mouse brain (Fig. 1C). As
demonstrated in Fig. 1B, chimeras expressed in fibroblasts and
comprising the extracellular domain of VLDLR (VVA, VAA)
are found in the NCM. In contrast, chimeras containing the
extracellular domain of ApoER2 (AAV, AVV) follow the distri-
bution ofWTApoER2 independently of the composition of the
remaining parts of the receptors. Thus, the extracellular
domain of ApoER2 determines its sorting to raft domains of the
cell membrane.
This model system provides us with the opportunity to test
whether Reelin endocytosis, receptor degradation, or specific
receptor cleavage are determined by (i) specific molecular fea-
tures of the respective intracellular domains of the receptors or
(ii) their localization to raft or non-raft domains of the cell
membrane.
Endocytosis—To evaluate the efficiency of ApoER2 and
VLDLR to endocytose and degrade Reelin, we used fibroblast
cell lines engineered to express selected components of the
Reelin signaling pathway (23). The cells (3T3 V; 3T3 A) were
incubated with Reelin at 4 °C to allow binding of the ligand.
After washing the cells, Reelin-free medium was added, the
cells were shifted to 37 °C, and at the indicated time points,
cell-associated Reelin was measured byWestern blotting using
antibody G10, which interacts with full-length Reelin and the
proteolytic fragments NR6 and NR2 (see supplemental Fig. 2).
Because endocytosis and degradation of full-length Reelin
and both fragments follow a similar kinetic (supplemental Fig.
2), only full-length Reelin is shown in the following figures. As
demonstrated in Fig. 2, cells expressing VLDLR (3T3 V)
degrade associated Reelin extremely quickly. After 12 min,
more than 60%, and after 24 min, all of the detectable cell-
associated Reelin was lost. In cells expressing ApoER2 (3T3 A),
however, bound Reelin remained stably associated with the
cells, slowly dropping to 75% of the starting level after 24min of
incubation at 37 °C (Fig. 2B). As control, we used the parental
3T3 cells not expressing any of the two receptors. These cells do
not interact with Reelin, demonstrating that binding and sub-
sequent loss of Reelin is dependent on the presence of the
receptors. To test whether the effect is cell-specific, we tran-
siently transfected HeLa cells with ApoER2 and VLDLR and
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performed the same set of experi-
ments. ApoER2- and VLDLR-medi-
ated Reelin degradation followed
the same kinetic as demonstrated
for fibroblasts (data not shown).
Thus, independent of cell type,
VLDLR exhibits a high internaliza-
tion rate leading to a fast removal of
the ligand from the cell surface. In
contrast, ApoER2, which resides in
rafts,mediates very little Reelin deg-
radation within the time frame rele-
vant to Reelin signaling (20 min).
To evaluate whether Reelin is en-
docytosed by VLDLR and ApoER2
via the same intracellular pathway,
we prepared CCVs from cell lysates
and analyzed the content of this
preparation by Western blotting.
3T3 cells expressing either ApoER2
or VLDLR and cultured primary
neurons from WT rats were incu-
bated in the presence of Reelin for
60 min and washed, and the CCVs
were prepared and tested for the
presence of the respective receptor
and Reelin (Fig. 3). In 3T3 cells, Ree-
lin and the corresponding receptor
were always present in the CCV-en-
riched fraction, independent of the
receptor expressed (Fig. 3A). Note
that in CCV, only the mature form
of ApoER2 is present, as expected.
In primary neurons derived from
WT rats that express VLDLR and
ApoER2, Reelin and both receptors
were present in the CCV prepara-
tion. In an alternative approach, we
studied this process by immuno-
fluorescence microscopy (Fig. 4).
3T3A and 3T3V cells were incu-
bated at 4 °C with Reelin to allow
receptor binding of the ligand in
the absence of membrane-depen-
dent endocytosis. Then the cells
were incubated in Reelin-free me-
dium for 10 min at 4 °C or 37 °C
and fixed and processed for immu-
nostaining with antibodies against
Reelin, the respective receptor,
and EEA1, respectively. As demon-
strated in Fig. 4A, cells expressing
ApoER2 or VLDLR incubated with
Reelin at 4 °C exhibit prominent
staining for Reelin outlining the cell
surface. This staining is not contin-
uous but shows a punctuate pattern
that co-localizes with that obtained
FIGURE 1. Localization of ApoER2, VLDLR, and chimeric receptors within the plasmamembrane. A, sche-
matic presentation of chimeric receptors consisting of intracellular, transmembrane (TM), and extracellular
domains of ApoER2 (A) and VLDLR (V), respectively. Epitopes of the antibodies used are marked in the sche-
matic diagram of the WT receptors. B, 3T3 cells expressing either of the receptors were fractionated by density
centrifugation toprepareCLMandNCMfractions asdescribedunder “Experimental Procedures.” Thepresence
of the respective receptor was analyzed by Western blotting using Ab 20 for detection of ApoER2, VVA, and
VAA and Ab 6A6 for detection of VLDLR, AAV, and AVV. Filled and open arrows indicate mature ApoER2, AAV,
and AVV receptors and their unglycosylated precursors, respectively. The quality of the fractionation proce-
dure was controlled by analyzing the presence of caveolin 1 by Western blotting using an anti-caveolin anti-
body. C, total brain extracts of embryonic WT mice (embryonic day 15; E15) were treated and analyzed as
described above to detect the indicated proteins in CLM and NCM.
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with antibodies against the respective receptors. Under these
conditions (endocytosis is blocked at 4 °C), Reelin does not
co-localize with intracellular EEA1 (Fig. 4, B and C, 4 °C).
After 10 min at 37 °C, Reelin appears in vesicular structures
co-localizing with EEA1, independently of the receptor
expressed. Together with the results obtained from the anal-
ysis of coated vesicles (Fig. 3), these data suggested that Ree-
lin endocytosed via ApoER2 fol-
lows the same route as Reelin
taken up by VLDLR (i.e. via clath-
rin-coated vesicles).
Having established that internal-
ized ApoER2 and VLDLR follow the
same pathway, we set out to investi-
gate whether the different endocy-
tosis rates for ApoER2 and VLDLR
are due to their distinct membrane
localization. Thus, internalization
rates of Reelin were determined as
performed for the WT receptors
(Fig. 2) using cells expressing the
different chimeric receptor con-
structs described in the legend to
Fig. 1. As demonstrated in Fig. 5A,
chimeric receptors containing the
extracellular domain derived from
ApoER2 exhibited the same endo-
cytosis kinetics asWTApoER2. The
chimeras containing the extracellu-
lar domain of VLDLR, however,
removed Reelin from the cell sur-
face with the same rate as WT
VLDLR (Fig. 5B). Thus, the receptor
domains responsible for specific
membrane localization of the re-
ceptors also determine their endo-
cytosis rates. To test this notion
further, cells expressing ApoER2
were treated with methyl--cyclo-
dextrin (CDX), which removes
cholesterol from the cell surface,
thereby dissolving the raft struc-
tures. Because depletion of choles-
terol also interferes with clathrin-
mediated endocytosis (31), we
determined the concentration of
CDX (5 mM) that did not affect
VLDLR-mediated Reelin endocy-
tosis (data not shown). As pre-
viously reported (23), this treat-
ment completely shifts ApoER2
into the non-raft fraction, and as
demonstrated here (Fig. 5C), it
increased the ApoER2-mediated
Reelin endocytosis rate to that
observed with VLDLR. These
results demonstrate that the local-
ization to rafts, rather than an
intrinsic feature of the receptor, determines the slower
endocytosis rate of ApoER2 in comparison with VLDLR.
Reelin-mediated Dab1 phosphorylation is necessary (32)
but not sufficient to trigger the Reelin response in neurons
(12). To test whether Reelin endocytosis is linked to or nec-
essary for Dab1 phosphorylation, 3T3 cells expressing Dab1
and either ApoER2 or VLDLR (23) were exposed to Reelin at
FIGURE 2.VLDLRmediates Reelin endocytosismuchmore efficiently thanApoER2.A, 3T3 cells expressing
ApoER2 or VLDLR or mock-transfected 3T3 cells were incubated with RCM at 4 °C to allow binding of Reelin to
the respective receptors. Cells were then shifted to 37 °C for the indicated time periods to allow internalization
and degradation of the ligand. Extracts were prepared and analyzed for cell-associated Reelin by Western
blotting using Ab G10 in combination with an HRP-coupled goat anti-mouse antibody. B, Western blots of A
and two identical independent experiments were quantified by densitometry, and IOD values of the bands
were normalized to the density of the band corresponding to the first time point. Error bars, S.E. (n 3).
FIGURE3.ApoER2andVLDLR internalizeReelin via clathrin-mediatedendocytosis.A, 3T3 cells expressing
either ApoER2 or VLDLR were incubated with RCM for 1 h, and CCVs were prepared from total cell lysates (CL)
as described under “Experimental Procedures.” The presence of Reelin and the respective receptors was ana-
lyzed by Western blotting using the appropriate antibodies and the corresponding HRP-coupled secondary
antibodies. Clathrin heavy chain was detected as control for enrichment of CCVs. B, CCVs were prepared from
primary rat neurons and analyzed as described above.
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37 or 4 °C. ApoER2 and VLDLR
were both able to mediate Dab1
phosphorylation not only at 37 °C
but importantly also at 4 °C (sup-
plemental Fig. 3), demonstrating
that Reelin endocytosis is not nec-
essary for the primary signaling
event.
Receptor Degradation and Pro-
cessing—We have previously ob-
served that in 3T3 cells expressing
ApoER2, the receptor becomes dra-
matically down-regulated/degraded
upon Reelin stimulation (23). To
test whether the loss of ApoER2 is a
specific feature of the 3T3 cell sys-
tem and is mediated by the Reelin
signaling cascade, we studied this
effect in more detail. Primary rat
neurons were stimulated for 5 h
with Reelin, and the levels of
ApoER2 and VLDLR were subse-
quently assessed by Western blot-
ting (Fig. 6A, lanes 1 and 4). This
treatment resulted in a significant
loss of ApoER2, whereas VLDLR
levels remained unchanged when
compared with treatment with
mock medium. Next, neurons and
3T3A cells were treated with Ab
186, which targets the extracellular
domain of ApoER2 (see Fig. 1A) and
induces Dab1 phosphorylation via
receptor-clustering (23). As demon-
strated in Fig. 6, A (lane 3; neurons)
and B (lane 2; 3T3), treatment with
Ab 186 also led to a dramatic loss of
ApoER2. The effect of this antibody
is specific because it could be
blocked by the addition of soluble
receptor fragment (Fig. 6B, lane 3,
MBP-ApoER2), and an antibody
against the intracellular domain of
ApoER2 (Ab 20) had no effect (Fig.
6B, lane 1). The addition of recep-
tor-associated protein, which binds
to the receptors without inducing
clustering and Dab1 phosphoryla-
tion had no effect (Fig. 6B, lane 4).
These findings indicate that the loss
of ApoER2 is mediated by receptor
clustering and not merely by ligand
binding and is a specific feature of
ApoER2 but not of VLDLR. To test
whether Reelin-mediated degrada-
tion of ApoER2 occurs via the lyso-
somal or the proteasomal pathway,
we used specific inhibitors. The
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addition of the lysosomal blockers NH4Cl and chloroquine
reduced the degradation of ApoER2 (Fig. 6C), whereasMG132,
an inhibitor of proteasomes, did not. From the results pre-
sented in Fig. 6 and those showing that ApoER2 is endocytosed
via coated vesicles and early endosomes (Figs. 3 and 4), we con-
clude that ApoER2 is endocytosed via the coated pit/coated
vesicle/endosome pathway and becomes degraded in the lyso-
some despite its localization in raft domains. Next, we evalu-
ated the stability of the chimeric receptors. 3T3 cells expressing
the individual chimeric receptors were treated with Reelin, and
the fate of the receptors was evaluated byWestern blotting. As
demonstrated in Fig. 7A, all receptor variants containing the
extracellular domain of ApoER2 became degraded upon Reelin
stimulation, whereas variants containing the corresponding
domain of VLDLR did not change their abundance. Reelin-in-
duced degradation is not specific for raft-associated ApoER2,
however, because raft-dissolving agents like CDX (Fig. 7B) or
nystatin (Fig. 7C) did not inhibit this process.
Another aspect of the Reelin signaling cascade is the Reelin-
induced cleavage of ApoER2, which produces a soluble extra-
cellular (NTF) and a soluble intracellular fragment (intracellu-
lar domain; ICD) by the sequential action of - and -secretase,
respectively (33, 34) (Fig. 8A). Because the production of the
intracellular domain cannot be monitored directly, most likely
due to its inherent instability (34), we followed the production
of the membrane-bound precursor CTF by Western blotting.
Incubation of 3T3 cells expressing WT ApoER2 with Reelin
resulted in a significant increase of the 25-kDa CTF (supple-
mental Fig. 4, lane 1), which was not observed upon the addi-
tion of receptor-associated protein (lane 3). Again, CTF pro-
duction could be triggered by the bivalent agentAb 186 (lane 5),
and this was blocked by the addition of soluble receptor frag-
ment (lane 6). For controls, the cells were incubatedwithmock-
conditioned medium (lane 2) and Ab 20 (directed against the
intracellular domain; lane 4). Under these conditions, small
amounts of CTF were detected, apparently produced even
when the cells are not stimulated. The properties of the chi-
meric receptors in regard to the specific fragmentation process
(Fig. 8B) were more complex than those described above for
receptor degradation and endocytosis. Although VLDLR does
not undergo fragmentation at all (Fig. 8C, lane 1), chimeras
containing the extracellular domain of ApoER2 produced sig-
nificant amounts of CTF upon Reelin treatment (Fig. 8C, lanes
3 and 5). It should be noted that the antibody used (6A6) to
detect the CTF containing the respective domains of VLDLR
consistently gives weaker signals than Ab 20 directed against
the intracellular domain of ApoER2. Chimeras containing the
transmembrane plus intracellular domains (VAA) or only the
intracellular domain of ApoER2 (VVA) are processed to a small
extent, but this was not enhanced by Reelin (Fig. 8B, lanes 3–6).
Disruption of rafts using CDX significantly blocked the Reelin-
induced production of CTF fromWT ApoER2 (Fig. 8D).
DISCUSSION
Inactivation of the genes for both Reelin receptors, ApoER2
and VLDLR, leads to a reeler phenotype in mice (25). Single
knock-out mice lacking the gene either for ApoER2 or for
VLDLR display only subtle abnormalities in their brain archi-
tectures. This suggests that ApoER2 and VLDLR can at least
partially compensate for each other, at least in respect to their
function in establishing laminated brain structures. This was
confirmed in primary neurons and in a fibroblast cell model by
FIGURE 4. ApoER2 and VLDLR internalize Reelin via the early endosomal compartment. A, Reelin co-localizes with ApoER2 and VLDLR at 4 °C. 3T3 cells
expressing ApoER2 (upper panel) or VLDLR (lower panel) were incubated with RCM at 4 °C to allow binding of Reelin to the receptors. Cells were fixed,
permeabilized, and stained using Ab 186 for detection of ApoER2, Ab 187 for VLDLR, and Ab G10 for Reelin. B and C, internalized Reelin co-localizes with EEA1.
3T3 cells expressing ApoER2 (B) or VLDLR (C) were incubated with RCM at 4 °C for 1 h, washed, and incubated with Opti-MEM for 10 min at 4 °C (upper panels)
or 37 °C (lower panels), respectively. Cellswere fixed, permeabilized, and stainedusingAbG10 for detection of Reelin and an antibody against EEA1 for staining
of the early endosomal compartment. Scale bars, 10 m.
FIGURE 5. Reelin internalization and degradation rates of ApoER2 and
VLDLR depend on their sorting within the plasma membrane. 3T3 cells
expressing ApoER2 or one of the chimeric receptors containing the extracel-
lular domain of ApoER2 (A) or VLDLR or one of the chimeric receptors
containing the extracellular domain of VLDLR (B) were incubated with RCM at
4 °C to allow binding of Reelin to the respective receptors. Cells were then
shifted to 37 °C for the indicated time periods to allow internalization and
degradationof the ligand.Afterwashing thecells, extractswerepreparedand
analyzed for cell-associated Reelin by Western blotting using Ab G10 in com-
binationwith anHRP-coupledgoat anti-mouse antibody.C, 3T3 cells express-
ing ApoER2 were treated as described for A in the presence (lower panel) or
absence (upper panel) of the raft-disrupting agent CDX (5 mM). Cell extracts
were analyzed as described for A.
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demonstrating that the initial event of the Reelin signaling
pathway (i.e. phosphorylation of Dab1) is equally well sup-
ported by ApoER2 and VLDLR (11, 23). Divergent roles for
ApoER2 and VLDLR have been corroborated recently. In neu-
ronal migration, VLDLR mediates a stop signal for migrating
neurons, whereas ApoER2 plays a distinct role in the migration
of neocortical neurons generated late (26). The specific pheno-
types of the single knock-out animals and the observed distinct
roles for both receptors might be in
part caused by selective expression
of the receptors in distinct areas of
the brain (35). On the other hand,
ApoER2 and VLDLR may have dis-
tinct functions in the Reelin path-
way, apart from the primary phos-
phorylation event. Other processes
in the central nervous system seem
to depend on specific variants of
ApoER2 only and involve the mod-
ulation of synaptic plasticity and
memory (36), the control of neuro-
nal survival (37), and selenium
uptake (38, 39). One reason for dif-
ferential functions of these recep-
tors is structural differences in the
respective intracellular domains
(40) linking ApoER2 to adapters
that do not interact with VLDLR
(41). Other features could be selec-
tive expression in distinct subdo-
mains of the cell membrane and/or
their divergent endocytic compe-
tence. As shown in our laboratory,
ApoER2 is prevalently present in
raft domains, whereas VLDLR is not
(23). The avian ortholog of VLDLR
is expressed on growing oocytes
where it efficiently mediates recep-
tor-mediated endocytosis of yolk
precursors, thus playing a pivotal
role in follicle development (42),
whereas ApoER2 was demonstrated
to exert an extremely slow endocy-
tosis rate in comparison with other
members of the LDL receptor fam-
ily (43). As recently postulated,
VLDLR and/or ApoER2-mediated
endocytosis of full-length Reelin or
its central fragment produced by
metalloproteinases might play an
important role in the Reelin signal-
ing pathway by controlling the
strength of the signal via modulat-
ing the availability of the ligand (44).
Thus, we set out to study structural
features of the receptors that might
be responsible for different fates
and/or functions of the receptors in
terms of cellular sorting, endocytosis, and receptor trafficking.
For most of the present studies, we used a recently estab-
lished fibroblast-based cell system inwhich the Reelin signaling
pathway has been partially reconstituted by expressing Dab1
and either ApoER2 or VLDLR (23). These cells respond to Ree-
lin stimulation with Dab1 phosphorylation and phosphatidyl-
inositol 3-kinase activation, leading to protein kinase B/Akt
phosphorylation undistinguishable from primary neurons. In
FIGURE 6. ApoER2 degradation is induced by multivalent ligands and is mediated by the lysosomal
pathway. Primary rat neurons (A) and 3T3 cells expressing ApoER2 (B) were incubated for 5 h with RCM, MCM,
Ab 186 (1:100; targets ApoER2 ligand binding domain), Ab 20 (1:100; targets ApoER2 intracellular domain), Ab
186 and recombinant ApoER2 N-terminal fragment (MBP-ApoER2), or 20 g/ml recombinant receptor-associ-
ated protein (RAP). Total cell extracts were analyzed by Western blotting using Ab 20 (ApoER2) and Ab 6A6
(VLDLR) andanantibody against Lis1 as a loading control in combinationwith the correspondingHRP-coupled
secondary antibodies. C, ApoER2-expressing 3T3 cells were incubated with RCM or MCM. Lysosomal degrada-
tionwas blockedby the addition of 10mM NH4Cl or 25M chloroquine; proteasomal degradationwas blocked
using 25 M MG132. Cell extracts were analyzed as described for A and B, and results were quantified by
densitometry. IOD values of ApoER2bandswere normalized to the density of Lis1 bands. Error bars, S.E. (n 3).
FIGURE 7. The extracellular domain of ApoER2 but not its sorting to lipid rafts is required for Reelin-
induced lysosomal receptor degradation. A, 3T3 cells expressing one of the wild type (A and V) or chimeric
receptors (AVV, AAV, VAA, and VVA) were stimulated with RCM (lanes 1, 3, 5, 7, 9, and 11) or MCM (lanes 2, 4, 6, 8,
10, and12) for 5h andanalyzed for receptor degradationbyWesternblottingusingAb20 forApoER2, VAA, and
VVA; Ab 220 for AAV and AVV; and Ab 74 for VLDLR. Lis1 was highlighted using an anti-Lis1 antibody and used
as a loading control. B, ApoER2-expressing 3T3 fibroblasts were incubated with RCM (lanes 1 and 3) or MCM
(lanes 2 and 4) and the raft-disrupting agent CDX (5 mM; lanes 3 and 4) for 5 h. Cell extracts were analyzed for
ApoER2 degradation by Western blotting using Ab 20 in combination with an HRP-coupled goat-anti-rabbit
antibody. Lis1 was highlighted using an anti-Lis1 antibody and used as a loading control. C, cells were treated
and analyzed as described for B, except that 15 g/ml nystatin was used for disruption of rafts.
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addition, we have now used a panel of genetically engineered
receptor chimeras between ApoER2 and VLDLR (Fig. 1A) to
define the structural elements in the receptors responsible for
differential sorting of the receptors. These chimeric receptors
were also used to determine whether functional differences are
caused by selective expression in raft versus non-raft domains
or by intrinsic structural differences of the respective receptors.
As previously demonstrated by analysis of whole cell
extracts (23), ApoER2 migrates as a distinct double band
representing the precursor (lower band) and the fully glyco-
sylated mature form (upper band), which is present in the
raft domains of the plasma membrane. Expression of the
chimeric receptors corroborates these findings, as the extracel-
lular part ofApoER2 containing theO-linked sugar domain (45)
directs the receptors to the raft fraction, whereas all constructs
containing the extracellular domain of VLDLR did not show
this behavior (Fig. 1B). Ligand blotting and evaluation of Ree-
lin-induced and receptor-mediated Dab1 phosphorylation
demonstrated that all chimeric receptor constructs are Reelin
binding-competent (supplemental
Fig. 1B) and transmit the signal into
the cells equally well (supplemental
Fig. 1C). Membrane fractionation
studies allowed us to identify the
extracellular domain of ApoER2 as
the one responsible for directing the
receptor to caveolae/rafts. This is
reminiscent of epidermal growth
factor receptor, which is also sorted
to rafts; there, the responsible
regionwas identified to bewithin 60
amino acids of the extracellular
domain juxtaposed to the cell mem-
brane representing the O-linked
sugar domain (46). As reported in
the same paper, glycosylation of this
domain is indeed the key to such
sorting, since when glycosylation is
blocked, epidermal growth factor
receptor is targeted to non-raft
membrane domains. This is an
interesting observation, because the
predominant variant of VLDLR
expressed in the brain lacks exactly
this domain and is absent from the
raft fraction (23). The fact that
the sorting signal derives from the
extracellular domain of the recep-
tors allowed us to dissect whether
specific functions of the receptors
are due to their differential sorting
or to structural differences in their
respective intracellular domains.
The major finding of these stud-
ies is that VLDLR indeed internal-
izes Reelin very efficiently, resulting
in a local depletion of Reelin.
ApoER2, in contrast, endocytoses
Reelin with very low efficiency, and cells expressing ApoER2 do
not significantly decrease the concentration of Reelin in the
medium. Although localized in the raft fraction of the plasma
membrane, slow endocytosis of ApoER2 takes place via the
classic endocytosis pathway involving coated pits/coated vesi-
cles/early endosomes (Figs. 3 and 4). This is in agreement with
previous findings demonstrating that ApoER2 is endocytosed
independent of its raft association by a clathrin-mediated proc-
ess involving the adapter Dab2 (22). It was demonstrated that
the central fragment (R3-6) is critical to exert the signaling
function of Reelin, suggesting that this domain of Reelin inter-
acts with ApoER2 and VLDLR (12). The presence of NR2,
which lacks the central part of Reelin (R3-6), in coated vesicles
suggests that this fragment either stays associated with full-
length Reelin via the oligomerization domain present in the
N-terminal region (47) or that NR2 is produced after endocy-
tosis. Using the panel of chimeric receptors and raft-dissolving
agents likeCDX,we demonstrate that it is the raft association of
ApoER2 that causes its slow endocytosis rate. As soon as
FIGURE 8. Secretase-mediated cleavage of ApoER2 depends on the sorting of the receptor to lipid rafts.
A, ApoER2 is subjected to cleavage by -secretase upon Reelin stimulation, thereby producing a soluble
extracellularN-terminal fragment (NTF) andamembrane-boundC-terminal fragment (CTF). The latter is further
processedby-secretase to release a soluble intracellular domain (ICD).B andC, 3T3 fibroblasts expressingone
of the WT (A and V) or chimeric receptors (VAA, VVA, AVV, and AAV) were stimulated with RCM or MCM. Cell
extracts were analyzed byWestern blotting using Ab 20 for detection of the CTF derived fromA, VAA, and VVA
(B) and Ab 6A6 for the CTF derived from V, AVV, and AAV (C). D, 3T3 cells expressing ApoER2 were treated as
described forBandC in thepresence (lanes 3and4) or absence (lanes 1and2) ofCDX. Productionof theCTFwas
analyzed as described for B. Lis1 was highlighted using an anti-Lis1 antibody and used as a loading control. FL,
full-length.
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ApoER2 loses its association with rafts, the endocytosis rate of
the receptor increases significantly. This effect might even be
underestimated by the experiment using CDX to dissolve the
rafts because this agent also blocks clathrin-dependent endocy-
tosis by generally depleting the membrane of cholesterol (31).
Thus, slow translocation from rafts to non-raft domains of the
membrane might be the rate-limiting step of ApoER2-medi-
ated endocytosis.
The second significant difference between ApoER2 and
VLDLR is the fact that the levels of ApoER2, but not of VLDLR,
significantly drop in the presence of Reelin (23). As demon-
strated here, Reelin-induced degradation of ApoER2 occurs via
the lysosomal pathway and depends on the presence of recep-
tor-clustering ligands. Again, the extracellular domain of
ApoER2 determines the fate of the receptor upon binding of
Reelin. Disruption of rafts by CDX or nystatin had no influence
on receptor degradation, demonstrating that neither the caveo-
lin-mediated pathway originating from raft structures nor the
targeting of raft-associated receptors to endosomes (48) is
responsible for receptor degradation. Thus, ApoER2 degrada-
tion most likely occurs by clathrin-mediated endocytosis and
subsequent sorting to lysosomes. Structural differences in the
extracellular domains of ApoER2 and VLDLR must be respon-
sible for directing ApoER2 predominantly to lysosomes and
VLDLR into the recycling pathway back to the plasma mem-
brane. For the LDL receptor, it was shown that a distinct region
of the extracellular domain (i.e. the cysteine-rich growth factor
repeats (epidermal growth factor repeats)) is responsible for
uncoupling of receptor and ligand within the endocytic path-
way (49). When this domain is deleted, the receptor no longer
releases its ligand andbecomes degraded in the lysosome.Thus,
we speculate that differences in the epidermal growth factor
repeats between ApoER2 and VLDLR are responsible for the
distinct behavior of the receptors.
Parallel to lysosomal degradation of ApoER2, specific break-
down products of this receptor are produced upon Reelin stim-
FIGURE 9. Model of the intracellular fates of ApoER2 and VLDLR upon Reelin stimulation. Upon binding of Reelin, both ApoER2 and VLDLR mediate
phosphorylation of Dab1 (step 1). VLDLR internalizes Reelin rapidly via clathrin-mediated endocytosis (step 2) and is separated fromReelin in the compartment
of uncoupling of receptor and ligand (step 3). VLDLR then recycles back to the plasma membrane (step 4), whereas Reelin is delivered to the lysosome for
degradation (step 5). ApoER2 internalizes Reelin via the same pathway (step 2), although the receptor originally resides in lipid rafts and endocytoses its ligand
at a much slower rate. In contrast to VLDLR, ApoER2 is not recycled but ends up in the lysosome together with Reelin (step 6). As an additional feedback
mechanism, Reelin stimulation induces secretase-mediated cleavageofApoER2, therebygenerating a soluble intracellular fragment (ICD) (step 7), the function
of which is not defined yet, and a soluble extracellular fragment containing the ligand binding domain (step 8). This fragment can, together with another
N-terminal fragment produced from an ApoER2 isoform by furin cleavage (step 9), inhibit the Reelin signal by sequestering free Reelin in the surroundings of
the cell (step 10).
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ulation (33, 34). Here we demonstrate that this effect (i) is not
simply induced by binding of a ligand but requires the presence
of a clustering ligand, such as Reelin, or antibodies against the
extracellular domain, which also induceDab1 phosphorylation;
(ii) is dependent on the presence of the extracellular domain of
ApoER2; and (iii) is dependent on the presence of rafts. VLDLR
variants carrying the extracellular domain of ApoER2 are
cleaved like ApoER2 itself, whereas intact VLDLR completely
escapes this process. This is in agreement with previous find-
ings that the presence of the O-linked sugar domain pro-
motes -secretase-mediated cleavage of the receptor (34)
and that the -secretase complex is associated with rafts (50,
51). Thus, most likely, the entire processing (- and -secre-
tase-mediated) takes place within the raft domain of the plasma
membrane. Whether clustering of the receptors or Dab1 phos-
phorylation or both actually triggers the induction of the cleav-
age is still an open question.
These results allow us to propose amodel for describing both
the interrelated and independent functions of ApoER2 and
VLDLR in Reelin signaling (Fig. 9). VLDLR present in non-raft
domains of the plasmamembrane binds Reelin, which results in
Dab1 phosphorylation (Fig. 9, step 1). The Reelin-receptor
complex is rapidly internalized by clathrin-mediated endocyto-
sis (Fig. 9, step 2), and Reelin is uncoupled from the receptor
(Fig. 9, step 3) and sorted to lysosomes (Fig. 9, step 5), whereas
VLDLR recycles back to the cell membrane (Fig. 9, step 4). This
reduces the amount of extracellular Reelin significantly, thus
shutting off the persistence of the signal without rendering the
cell refractory toVLDLR-mediated actions. Binding of Reelin to
ApoER2 present in rafts also leads to immediate phosphoryla-
tion of Dab1 (Fig. 9, step 1) but not to a significant reduction of
extracellular Reelin, because ApoER2-mediated endocytosis is
slow. The Reelin signal itself can be turned off via degradation
of phosphorylated Dab1, which occurs independently of the
signaling receptor (52). Selective Reelin-mediated loss of
ApoER2 depends on clathrin-mediated endocytosis and lysoso-
mal degradation of the receptor (Fig. 9, step 6). As shown here,
this process is much slower than for VLDLR but in the long run
renders the target cell refractory to further Reelin stimulation
until new receptor is synthesized. In parallel, specific fragmen-
tation by - and -secretases leads to the production of soluble
intracellular receptor fragment (Fig. 9, step 7), which might
exert its action within the nucleus (34), and a soluble extracel-
lular fragment (Fig. 9, step 8). The extracellular fragment con-
taining the ligand binding domain, together with secreted sol-
uble ApoER2 fragments (Fig. 9, step 9) produced by the action
of furin from certain splice variants of the receptor (28), bind
Reelin and thereby attenuate the entire pathway (Fig. 9, step 10).
Thus, in regions of the brain where mostly ApoER2 is
expressed, the Reelin-induced activation of target cells is not
accompanied by a reduction of Reelin. Thus, Reelin might keep
exerting other functions without further inducing the canoni-
cal Reelin signal, which is efficiently turned off by Dab1 degra-
dation and production of dominant negative receptor frag-
ments. Whether the production of soluble intracellular
fragments derived fromApoER2 by -secretase cleavage repre-
sents an independent signal within the cell as proposed (34)
awaits clarification.
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Supplemental Figure 1: Expression and functional characterization of chimeric receptors. (A) wt 
receptors (lanes 1 and 2) and chimeric receptors (lanes 3-6) were expressed in 3T3 fibroblasts, total cell 
extracts were separated by SDS-PAGE and the receptors analyzed by Western blotting using the indicated 
antibodies in combination with the appropriate HRP-coupled secondary antibodies. Mock transfected 3T3 
fibroblasts (lane 7) were used as control. (B) Total cell extracts derived from cells expressing ApoER2 
(lane 1), VLDLR (lane 4) or the respective chimeric receptors (lanes 2, 3, 5, 6) were separated by SDS-
PAGE and the receptors analyzed by ligand blotting using Reelin as ligand. Bound Reelin was detected 
by incubating the blots with an antibody against Reelin (G10) in combination with an HRP-coupled goat-
anti-mouse antibody. (C) Dab1 phosphorylation mediated by wt (lane 1, 2, 7, and 8) and chimeric 
receptors (lanes 3-6 and 9-12). 3T3 cells expressing one of the receptors and Dab1 were incubated with 
RCM or MCM for 30 minutes and Dab1 was immunoprecipitated from cell extracts and analyzed by 
Western blotting using antibodies against Dab1 and phosphorylated tyrosine in combination with an 
HRP-coupled goat-anti-mouse antibody. 
 
Supplemental Figure 2: Full-length Reelin and Reelin fragments show similar endocytosis and 
degradation kinetics. (A) Reelin is cleaved at two sites, generating three fragments and two 
intermediates. Reelin antibody G10 recognizes N-R6 and N-R2 in addition to full length Reelin. (B) 
Western blot partially presented in Fig. 3A. 3T3 cells expressing ApoER2 or VLDLR were incubated 
with RCM at 4°C to allow binding of Reelin to the respective receptors. Cells were then shifted to 37°C 
for the indicated time periods to allow internalization and degradation of the ligand. Cell extracts were 
prepared and analyzed for cell-associated Reelin by Western blotting using Ab G10 in combination with 
an HRP-coupled goat-anti-mouse antibody. Black arrows indicate the respective Reelin fragments. 
 
Suppemental Figure 3: Dab1 phosphorylation is independent of Reelin internalization. 3T3 cells 
expressing Dab1 and either ApoER2 (lanes 1-4) or VLDLR (lanes 5-8) were incubated with RCM or 
MCM for 30 minutes at 4°C or 37°C to inhibit or allow endocytosis, respectively. Dab1-phosphorylation 
was measured by immuno-precipitating Dab1 from total cell extracts and analyzing the precipitate by 
Western blotting using antibodies against Dab1 and phosphorylated tyrosine in combination with an 
HRP-coupled goat-anti-mouse antibody. 
 
Supplemental Figure 4: Secretase-mediated cleavage of ApoER2 is induced by multivalent ligands. 
ApoER2-expresssing 3T3 fibroblasts were incubated for 5 h with RCM (lane 1), MCM (lane 2), 20 µg/ml 
recombinant RAP (lane 3), Ab 20 (lane 4, 1:100, targets ApoER2 intracellular domain), Ab 186 (lane 5, 
1:100, targets ApoER2 ligand binding domain), or Ab 186 and recombinant ApoER2 N-terminal 
fragment (lane 6, MBP-ApoER2) and total cell extracts were analyzed by Western blotting for ApoER2-
CTF (Ab 20 in combination with an HRP-coupled goat-anti-rabbit antibody). Caveolin1 was highlighted 
using a caveolin1 antibody and used as a loading control. 
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3.2.1 Materials and Methods
Cell lines, conditioned media, and antibodies were described in section 3.1. Cell culture, cell
extract preparation, SDS-PAGE, Western blotting were done as described ibidem.
GW3965 was purchased from Sigma and dissolved to a stock concentration of 1 mM in
DMSO.
RNA was prepared from cultured cells using TRI reagent (Molecular Research Center, Inc.)
and reverse transcribed to cDNA using the DyNAmo cDNA synthesis kit (Finnzymes) ac-
cording to the manufacturers’ protocols. cDNA was used for PCR with GoTaq Green poly-
merase Master Mix (Promega). Primers for detection of Abca1 and Idol of mouse and rat ori-
gin were designed using primerblast (NCBI) and purchased from VBC Biotech. The primers
were Abca1-S: 5’-CAGCAGCCTGTGGGGGCATC-3’, Abca1-AS: 5’-TGGCTGGAACCAG
GGTGGCT-3’, Idol-S: 5’-TGGCAGGCCACCTCCAGTGT-3’, and Idol-AS: 5’-GGGTGGC
CATCTGCACCACA-3’.
3.2.2 Results
It was recently shown that activation of liver X receptors leads to enhanced expression of the
ubiquitin ligase Idol and subsequent ubiquitination and degradation of LDL receptor (Zelcer
et al., 2009). Other members of the LDL receptor genefamily, namely LRP, MEGF7 and
SorLa were not affected by Idol expression, ApoER2 only marginally.
To investigate a possible LXR-dependent regulation of the two Reelin receptors ApoER2 and
VLDLR, the fibroblast model system previously established in our lab was employed. 3T3
cells expressing ApoER2 were incubated with or without the synthetic LXR ligand GW3965
for 6 h or 24 h, respectively and analysed for ApoER2 levels by Western blotting. As it is
shown in figure 3.1(A), LXR activation by GW3965 indeed led to a significant reduction of
receptor levels after 24 h of incubation (lane 3), compared to the negative control (DMSO,
lane 4). 6 h after addition of GW3965, only a slight reduction in ApoER2 levels could be
observed (lanes 1 and 2).
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As expected, GW3965-induced degradation of ApoER2 was found to only decrease the ma-
ture, fully glycosylated form of the receptor (upper bands) but not its ER-resident precursor
(lower bands). This confirms a role of the LXR-mediated pathway in posttranslational re-
ceptor degradation rather than targeting ApoER2 expression.
Figure 3.1 Influence of GW3965 on receptor degradation in fibroblasts. (A) 24 h incubation is
sufficient for GW3965-induced degradation of ApoER2. 3T3 fibroblasts stably expressing murine ApoER2
were incubated with 1 µM GW3965 in DMSO (lanes 1, 3) or DMSO (lanes 2, 4) for 6 h or 24 h. Cell extracts
were analysed by SDS-PAGE and Western blotting using AB 20. The two bands of ApoER2 represent mature
receptor (upper band) and its unglycosylated precursor (lower band). (B) GW3965 induces degradation of
both ApoER2 and VLDLR. 3T3 fibroblasts stably expressing murine ApoER2 (upper panel) or VLDLR
(lower panel) respectively, were incubated for 24 h with 1 µM GW3965 in DMSO (lane 1), DMSO (lane 2)
or were left untreated (lane 3). Cell extracts were analysed as described above using AB 20 for detection
of ApoER2 and Ab74 for detection of VLDLR. (C) Reelin-driven receptor degradation adds to GW3965-
induced degradation. 3T3 cells expressing one of the receptors were incubated for 24 h with GW3965 or
DMSO and subsequently stimulated with Reelin- or mock-conditioned medium containing either GW3965 or
DMSO, respectively for another 5 h. Cell extracts were analysed as described above.
Since 24 h of incubation with GW3965 were shown to be sufficient for induction of substensial
ApoER2 degradation, a possible effect of LXR activation on VLDLR was analysed using the
same time frame. As shown in figure 3.1(B), this treatment led to robust decrease of VLDLR
levels, similar to ApoER2 (compare lanes 1 and 2). To exclude any unspecific effect of DMSO,
receptor levels of cells incubated with or without DMSO were compared. Clearly, amounts
of ApoER2 and VLDLR could be shown to be unaffected by DMSO (compare lanes 2 and
3).
Previous results showed that upon endocytosis of Reelin, ApoER2 is delivered to the lyso-
some for degradation while VLDLR is recycled to the plasma membrane (section 3.1). The
mechanism for targeting ApoER2 to the lysosomal compartment is not yet clarified. How-
ever, since Idol-mediated degradation of LDLR has been shown to employ the lysosomal
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pathway, too (Zelcer et al., 2009), LXR/Idol-dependent ubiquitination is a candidate mech-
anism for Reelin-induced ApoER2 degradation. Reelin and LXR signaling might either be
required to cooperate to enable this regulative mechanism or Idol action might be a straight
downstream effect of Dab1 phosphorylation. The latter possibility is improbable however,
since cell lines used to demonstrate LXR-dependent degradation of ApoER2 and VLDLR
(figure 3.1(A and B)) do not express Dab1.
To investigate a possible link of LXR-mediated decrease of ApoER2 and VLDLR to Reelin-
induced degradation, receptor-expressing 3T3 cells were again exposed to 24 h treatment
with GW3965 or DMSO, followed by stimulation with Reelin- or mock-conditioned medium
(RCM/MCM, respectively) under continued supplementation with GW3965 or DMSO for
five more hours. For ApoER2 as well as VLDLR, GW3956 induced receptor degradation
both under Reelin stimulation and mock treatment (figure 3.1(C), compare lanes 1 and 2
for RCM, and 3 and 4 for MCM). VLDLR levels were unaffected by Reelin stimulation
which is in accordance with previous results. In the case of ApoER2 (upper panel), Reelin
induced degradation in DMSO-treated samples (compare lanes 2 and 4) as expected. Sup-
plementation with GW3965 however, led to further reduction of ApoER2 levels (lanes 2
and 4). This additive effect of LXR- and Reelin-mediated receptor degradation suggests a
Reelin-independent role of LXRs in the regulation of ApoER2 and VLDLR.
To study the effects of active LXR signaling on the Reelin pathway, the primary signaling
event, phosphorylation of Dab1 was examined. 3T3 cells expressing Dab1 and one of the
Reelin receptors were treated with GW3965/DMSO and RCM/MCM as described in figure
3.1(C). Dab1 was immunoprecipitated from protein extracts and precipitates were analysed
for phosphorylated Dab1 and total Dab1. As shown in figure 3.2, total Dab1 levels were
constant throughout preparations for cells expressing ApoER2 and Dab1 (A) and or VLDLR
and Dab1 (B). In both cases, Dab1 phosphorylation was induced by Reelin stimulation in
the control samples (DMSO) but was abolished in the presence of GW3965. This can be
explained by the dramatic LXR-induced decrease of available receptor able to relay the
Reelin signal to Dab1.
To verify LXR-driven degradation of ApoER2 and VLDLR in their native cell system, anal-
ysis was repeated using primary neurons prepared from E16.5 rat embryonic brains. Surpris-
ingly, no receptor loss could be observed in neuronal cultures treated with GW3965 (figure
3.3(A)).
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Figure 3.2 Influence of GW3965 on Dab1 phosphorylation in fibroblasts. 3T3 cells expressing
either (A) ApoER2 or (B) VLDLR and Dab1 were incubated with 1 µM GW3965 in DMSO or DMSO alone
for 24 h, starved in OptiMEM containing GW3965 or DMSO for 1 h, and stimulated with Reelin- or mock-
conditioned medium containing GW3965 in DMSO or DMSO for 40 min. Protein extracts were prepared
and Dab1 was immunoprecipitated. Phosphorylated Dab1 and total Dab1 were detected by Western blotting
using antibodies D4 for Dab1 and PY99 for phosphorylated tyrosine.
The unability of GW3965 to induce ApoER2 and VLDLR degradation in neuronal cells
could arise from disfunction of several steps in the mechanism. GW3965 might not be
able to activate LXRs in neurons, LXRs or Idol might not be expressed in these cells, or
Idol-mediated ubiquitination might be impaired.
To verify Idol expression in neuronal cultures, cDNA from neurons and 3T3 cells was sub-
jected to PCR using Idol-specific primers designed to target mRNA of both mouse and rat
origin, since neuronal cultures were prepared from rat embryos and 3T3 cells originate from
mouse. As shown in figure 3.3(B), Idol transcripts can be detected in both cell types.
To analyse the differences between 3T3 cells and neurons in terms of LXR activation, PCR
analysis using primers specific for rat and mouse Abca1, a classical target of LXRs, was
performed using cDNA from both cell types after incubation with or without GW3965.
As shown in figure 3.3(C), the Abca1 PCR product could be detected at the expected size
in all 3T3 and neuron samples. GW3965 supplementation however was only able to increase
Abca1 expression in 3T3 cells but not in samples from cultured neurons. This led to the
conclusion that activation of LXRs by GW3965 in neuronal cells is disturbed. PCR analysis
using primers specific for Idol was also done but has not yet been conclusive.
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Figure 3.3 No influence of GW3965 on primary neuronal cultures. (A) GW3965 does not induce
degradation of ApoER2 or VLDLR. Primary neuronal cultures were incubated for 24 h with 1 µM GW3965
in DMSO (lane 1), DMSO (lane 2) or were left untreated (lane 3). Cell extracts were analysed by SDS-
PAGE and Western blotting using AB 20 for detection of ApoER2 and Ab6A6 for detection of VLDLR. (B)
Neuronal cultures express Idol. cDNA from cultured neurons (lane 1) and 3T3 cells (lane 2) was used for PCR
analysis with primers Idol-S/Idol-AS (see section 3.2.1). (C) Abca1 expression is not induced by GW3965 in
neurons. cDNA from cultured neurons (lanes 1-3) and 3T3 cells (lanes 4-6) incubated with GW3965 (lanes
1 and 4) or DMSO (lanes 2 and 5) or without supplement (lanes 3 and 6) was used for PCR analysis with
primers Abca1-S/Abca1-AS (see section 3.2.1).
3.2.3 Discussion
Summarising the results generated with our fibroblast model system, it was shown that stim-
ulation of LXRs leads to a significant decrease of both ApoER2 and VLDLR levels, most
likely mediated by Idol-dependent ubiquitination and lysosomal degradation as proposed for
LDLR since this regulation does not target receptor expression but happens posttranslation-
ally.
Furthermore, the decrease of ApoER2 and VLDLR blocks the transmission of the Reelin
signal into the cell. Therefore, the LXR/Idol pathway could well constitute an additional
mechanism regulating the Reelin signaling cascade.
The original factor inducing this putative regulation cascade however, is not yet clear. Nev-
ertheless, a role of the LXR pathway as a feedback mechanism initiated by the canonical
Reelin pathway can be ruled out, since it can as well be induced in the absence of the pri-
mary signaling target of Reelin, Dab1. This leaves two possibilities for an involvement in
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the regulation of the Reelin pathway. First, LXR could be a downstream target of a par-
allel Dab1-independent, not yet defined route of Reelin signaling, and second, LXR might
be activated independently of Reelin in a pathway blocking the Reelin signaling cascade by
receptor degradation.
According to the data presented here, it seems likely that initiation of LXR-dependent
degradation of ApoER2 and VLDLR occurs Reelin-independently since it is cumulative to
receptor degradation caused by Reelin. Nevertheless, the latter could also be explained by
inefficient stimulation of LXRs present in the cell using the given GW3965 concentration, so
that Reelin signaling would be able to activate the remaining LXRs by a Dab1-independent
mechanism and thereby further enhance Idol expression. To analyse this possibility, Reelin-
induced receptor degradation would have to be examined in a situation where LXR or Idol
activity is blocked. This could be achieved by addition of a specific blocking reagent or by
downregulation of LXR expression using RNAi. If Reelin-mediated receptor loss was not
changed under these conditions, it would obviously not employ the LXR/Idol mechanism.
Although these results strongly support a regulative effect of LXR activation on the Reelin
signaling pathway, it is as well possible that in vivo, LXR and Idol do not play any role in
the regulation of the Reelin receptors. At least in primary neuronal cultures, no effect of
GW3965 supplementation on the receptor levels could be observed, although Idol mRNA
is present. Presumably, this might be due to the inability of GW3965 to activate LXRs
in neuronal cultures, since levels of Abca1, a classical LXR target were not affected either
by treatment with GW3956. This result has to be verified however, using a quantitative
method like realtime PCR. Furthermore, quantitative analysis using primers for Idol would
be important, since this is the relevant LXR target for the problem at hand. Under the
assumption that GW3965 is indeed unable to activate LXRs here, this could be explained
by a putative co-inducer present in 3T3 cells but not in neurons which is needed for LXR
activation. This hypothesis however remains to be investigated.
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